And too often, what gets said is some version of: “Your veins are just really rolly today.” Or, “Do people tell you you’re a tough stick?” Or my personal least favorite: “Did you drink enough water this morning?”

I want to make the case that we need to retire that habit. Not because those factors are never real — sometimes veins genuinely do roll, and sometimes a dehydrated patient really does present differently. The problem isn’t that these things can’t be true. The problem is when we say them out loud in the moment, they don’t function as information. They function as an excuse. And patients hear the difference.

Factors like dehydration can absolutely be worth discussing with a patient — just not as a reflex right after a miss. Missing a vein and immediately asking “did you drink water today?” reads as an excuse, and pointing blame at the patient. Missing a vein, apologizing, asking permission to try again, and later on asking about their hydration habits before their next appointment doesn’t land the same way at all. It’s about problem-solving for next time, not pointing a finger the moment the stick fails.

Why the Blame Reflex Backfires

Think about what a missed stick already does to a patient’s confidence. They came in trusting that you knew what you were doing, and now there’s a bruise forming and no tube filled. That trust just took a hit — a small one, maybe, but a real one.

Now imagine what happens if the very next thing out of your mouth is a comment about their veins. Even if it’s true, even if you don’t mean it as an accusation, what the patient hears from you is: this isn’t my fault, it’s yours. And if you won’t own what just happened, why would they feel confident letting you try again?

A missed stick is recoverable. A missed stick followed by a deflection or excuses is a lot harder to walk back.

Start Before You Ever Pick Up the Needle

Some of the best “recovery” work happens before there’s anything to recover from. Take a minute, before you tie the tourniquet, to actually talk to your patient. Ask which arm has worked well for them in the past. Get a little history — patients are often more than happy to share (or overshare sometimes). They’ll usually tell you which veins don’t work, or about past encounters with someone who struggled to find a vein on them.

Here’s where you’ll often hear the dreaded “I’m a tough stick” or “you’ll need a butterfly needle.” Those comments, while they can get old to hear over and over, are genuinely helpful to know. “Oh, you’ve been told you need a butterfly? Can you tell me more about that?” “Wow, that sounds like it was a painful experience, I’m sorry.” Listen to them and validate their concerns — that’s real insight into what you might be dealing with. Listening to them doesn’t mean you have to do what they say. Nine times out of ten, they’re not actually a tough stick, and they don’t actually need a butterfly needle — But they don’t know that, they are going off of what they have heard and experienced.

You’re the phlebotomist, and the call on equipment is yours to make, based on what you find, not just on what you’re told. Palpate. Look. Feel for the veins yourself, rather than assuming that because a patient says “I always need a butterfly” or “they always use my left arm,” that’s automatically the right call today. Patients remember what worked before; they don’t always remember why, and veins change between one draw to the next. If you palpate and find a great median cubital vein, assemble your 21-gauge straight needle and let the patient know that today, their veins look great and a butterfly isn’t necessary. Do this kindly, with a smile, without dismissing what they told you — the goal isn’t to prove them wrong, it’s to give them the best draw you can, informed by both what they said and what you found. Handled this way, it also tends to head off a lot of the friction that comes up when a patient walks in with strong opinions about how the draw should go.

This conversation is doing two jobs at once. You’re gathering genuinely useful clinical information, and you’re also building rapport. A patient who’s spent sixty seconds talking with you about their veins is a patient who already sees you as attentive and competent — before you’ve even touched them. That goodwill doesn’t disappear if the first stick doesn’t work. If anything, it’s exactly what makes a patient willing to say yes when you ask to try again. Sometimes listening and providing friendly education can completely change the outcome of what might have been a grouchy or demanding encounter.

When You Do Miss: Three Things, In Order

So the miss happens anyway. Here’s what should come next, in this order.

1. Own it, plainly. Not a spiral of apology, not silence — just a clear, factual acknowledgment. Something like: “I’m sorry, that one started to bruise so I stopped,” or “I’m sorry, I wasn’t able to get it that time.” No hedging, no blaming, no over-apologizing that makes the patient start comforting you.

2. Explain — but in ways that help the patient. An explanation should be part of the acknowledgment every time — the question is how much of one. Start simple: a short, factual line about what happened is usually enough. If the patient wants more — they ask a follow-up, or seem like they want to understand better — go into more detail from there. Either way, what you’re aiming for is an explanation that helps them understand, not one that’s really just a way of saying “not my fault.” The test is simple: are you explaining to inform them, or to excuse yourself?

The difference comes down to where the ownership sits. “I’m sorry, I missed that time — the vein rolled” still puts you at the center of it: you’re explaining what happened while owning that the miss is on you. “I’m sorry, I wasn’t able to get it — your veins are really rolly” says almost the same thing, but it lands as an accusation. Same basic information, same vein, same outcome — but one version takes the blame and the other hands it to the patient.

3. Ask permission, plainly. Something like, “Would it be okay if I tried again, maybe in the other arm?” This isn’t a formality. Give the patient a real chance to say no, or to ask for someone else. A genuine question, asked after a genuine acknowledgment, is what makes the next attempt feel like a choice they’re making with you rather than something happening to them.

What should not be happening, but is all too common, is saying nothing at all — and it isn’t actually the neutral option it might seem. “I’m going to have to poke again,” muttered while you’re already tearing open a new needle package, isn’t an acknowledgment — it’s a narration of what’s about to happen to the patient, not a conversation with them. From the patient’s side, this can feel worse than an awkward apology. There’s no acknowledgment that anything went wrong, no explanation of what’s changing, and no real question — just a decision that’s already been made for them. Silence in this moment doesn’t read as calm competence. It reads as a phlebotomist who doesn’t think the patient’s experience is worth pausing for.

It’s also worth remembering that the patient isn’t dumb. They just sat through the draw that didn’t go well, and they can often recognize or suspect what happened — they saw the needle move, felt it reposition, or noticed it come out without a tube filling. Pretending nothing happened, or describing it in vague terms that don’t match what they just experienced doesn’t spare them anything. It just tells them you’re not being straight with them.

Apologizing Isn’t the Liability Risk We Were Taught It Was

If you’ve been in this field a while, you may have come up under a different rule entirely: don’t apologize, don’t admit fault, because it could be used against you. For a long time, that was standard advice across healthcare — the thinking was that saying “I’m sorry” was tantamount to admitting a mistake, and admitting a mistake was a liability risk.

That thinking has largely reversed, and the research on it isn’t just about physicians and major adverse events — it holds up at all levels, from phlebotomists to physicians. A review of the nursing literature on error disclosure found that patients consistently want a handful of specific things when something goes wrong: an expression of remorse, empathy, a clear explanation, acknowledgment of responsibility, and some sign that steps are being taken so it doesn’t happen again. When those elements are present, patients respond better — but the same review found they’re often missing even when an apology is technically given, which tells you the apology itself isn’t the whole job. It’s worth noting, too, that this isn’t guaranteed: other research on nurse disclosure found patient reactions can still be mixed even with a genuine apology, which is a good reminder that how you own a mistake matters as much as whether you do.

That pattern — remorse, explanation, ownership, and a plan to do better — maps almost exactly onto the three steps above: own it, explain it honestly, and ask permission to try again. It’s not a coincidence. It’s the same basic human response to being let down by someone you trusted, whether the stakes are a missed vein or something much bigger.

On the higher-stakes end, the same pattern shows up in physician malpractice research. The University of Michigan Health System’s apology-and-disclosure program — real acknowledgment of what happened, not just a scripted “sorry” — has been credited with cutting malpractice payments and settlement times dramatically since it launched. That’s obviously a different scale of problem than a bruised antecubital, but the underlying principle is the same one this whole post is built around: patients who feel like the truth was addressed head-on tend to trust their care team more, not less.

That doesn’t mean confessing to negligence that didn’t happen, or turning every missed stick into a formal incident. It just means the instinct to stay quiet or vague to “protect yourself” is outdated — and it usually protects you less than just being honest would.

The Two-Stick Limit Isn’t Just Policy — It’s Part of the Trust

We should all work under some version of a two-attempt limit before we call for help or hand off to someone else. I think that limit does more than protect the patient’s arms. It protects the credibility of the apology itself.

“May I try once more?” means something different when the patient knows there’s a hard stop. It’s not an open-ended series of attempts disguised as politeness. It’s one more try, with a clear boundary, from someone who’s already shown they’ll own it if it doesn’t work. That’s a very different experience than feeling like you’re at the mercy of however many attempts someone wants to make.

If we can’t successfully obtain blood within two attempts, then the patient deserves someone else to come in and have a try. The more we attempt, the less trust the patient has in us. Plus, phlebotomy requires a lot of creative decisions. The next person may see veins or opportunities differently than we did, and use a different approach.

When the Second Try Doesn’t Work Either

Sometimes the second stick doesn’t go any better than the first. When that happens, the same principles apply — own it, and give the patient real options rather than just an apology and a shrug. Something like: “I’m so sorry I wasn’t able to draw your blood today. I can go get someone else to come in and try, if you’d like — or you’re welcome to come back tomorrow and we can try again then.”

It’s okay to miss twice. It’s part of being a phlebotomist. It improves a lot over time, but every phlebotomist, no matter how experienced, will have times where they miss — and while it can feel like a blow to your pride in the moment, how you handle it with the patient is where a different set of skills comes in, ones that matter just as much as your technique.

What This Sounds Like

Not this: “Hmm, did you drink any water leading up to your appointment? You need to be well hydrated for labs. I will need to poke again.”

This instead: “I’m sorry, that one didn’t work out — I’m going to look for a different spot. Would it be alright if I tried once more, maybe on your other arm?”

The first version blames the patient’s veins, skips any real acknowledgment, and doesn’t ask — it just announces what’s coming next. The second owns the miss, explains a genuine change in approach, and asks permission — all in about the same number of words.

The Takeaway

A missed stick is one of the few moments a patient actually gets to see what kind of phlebotomist you are. Anyone can look competent when the first stick works. What you do when it doesn’t — whether you own it cleanly, explain honestly, and ask rather than assume — is where real trust gets built. Sometimes more trust than a clean stick would have earned you in the first place.

Looking for phlebotomy training videos for your students or staff? We have excellent ones on various phlebotomy topics. Available on DVD or streaming!

Subscribe now

Share

Leave a comment

Sources

• Restoring trust: gratitude vs. apology in healthcare service recovery — Journal of Service Theory and Practice (2025): https://doi.org/10.1108/JSTP-05-2025-0176

• Prothero, M. M., & Morse, J. M. (2017). Eliciting the Functional Processes of Apologizing for Errors in Health Care: Developing an Explanatory Model of Apology. SAGE Open: https://journals.sagepub.com/doi/10.1177/2333393617696686

• A closer look at the role of apology in error disclosure: a simulation study — Frontiers in Health Services: https://pmc.ncbi.nlm.nih.gov/articles/PMC12170606/

• Disclosure of Errors — AHRQ Patient Safety Network (PSNet) primer, including the University of Michigan Health System apology-and-disclosure program data: https://psnet.ahrq.gov/primer/disclosure-errors

The device is Vitestro’s Aletta, the same autonomous robotic phlebotomy device I’ve mentioned here before. The study is called ADOPT — the Autonomous Blood Drawing Optimization and Performance Testing trial — and it was conducted across three hospital sites in the Netherlands between May and September 2025. It’s registered on ClinicalTrials.gov (NCT05878483), and it’s the most rigorous look yet at whether this technology actually performs the way the manufacturer says it does.

This study was funded by Vitestro, and the company had a hand in study design and manuscript preparation. That’s worth keeping in mind as you read the numbers. I look forward to seeing independent trials in the future.

How the device works

The Aletta uses a combination of near-infrared imaging, ultrasound, and Doppler to locate a vein, distinguish it from a nearby artery, and perform the stick. A patient places their arm in the device and presses a button. The system scans the antecubital area, applies alcohol prep, engages the tourniquet, and inserts the needle at a standardized angle between 10 and 30 degrees once it’s confident it’s found a suitable vein. Tubes fill, get inverted a fixed nine times regardless of tube type, and the needle withdraws with a bandage applied automatically. One trained staff member can supervise up to three devices running at once.

If the system can’t confidently identify a vein, it doesn’t guess. The patient is screened out and referred to a human phlebotomist instead. In this study, that happened for 6% of the people who came through.

What they actually measured

The trial had two parts. The first, a smaller cohort of 153 patients, checked whether blood drawn by the robot gave the same lab results as blood drawn manually — same patient, both arms, tested side by side. This mattered because the device inverts every tube nine times, which is more than several tube manufacturers recommend — most notably the light blue (citrate) tubes, where manufacturers call for as few as three to four inversions. More inversions can mean more mechanical stress on blood cells, so the question was whether that extra handling changed anything. It didn’t. Coagulation times, liver enzymes, and platelet counts all came back equivalent between the two collection methods.

The second and larger cohort, 1,633 patients, tested the device in day-to-day use, with no human comparison arm running alongside it.

The results

First-stick success sat at 94.5%, which lands right in the range reported for trained human phlebotomists in the literature (80% to 97%, depending on the study and setting). What stood out to me was how the device performed with the patients who usually give phlebotomists the most trouble. Success held at 92.7% for people with documented difficult venous access, 93.4% for patients 65 and older, and actually climbed to 97.4% for patients with obesity. The ultrasound guidance appears to be doing real work here, finding veins that aren’t visible or palpable on the surface.

Adverse events were rare and mild across the board: vasovagal reactions in 0.3% of draws, syncope in 0.1%, hematoma in 0.1%, and transient nerve-related sensations in 0.1%. All of those rates were at or below what’s been reported for manual phlebotomy in prior studies. Hemolysis came in at 0.3%, below typical laboratory benchmarks, which the authors attribute to the device’s consistency: the same tourniquet pressure, the same insertion speed, the same number of inversions, every single time.

Patients seemed to notice — ninety percent rated their pain as comparable to, less than, or far less than a typical manual draw. Eighty-two percent said they’d prefer the device next time, or had no preference either way.

This isn’t just a study anymore

While I was putting this post together, the ground shifted under it. Aletta has actually been available for clinical use in Europe since 2024, when it received CE marking — a Danish hospital pre-ordered three units as one of Vitestro’s first international deployments. In the US, the device had been research-only, with Northwestern Medicine, Mayo Clinic, and Baylor Scott & White Health serving as the first hospital partners running FDA trials.

That changed on August 19, 2026. The FDA authorized Aletta through the De Novo pathway, making it the first standalone robotic device cleared in the US to draw blood from a patient’s arm without hands-on operator intervention. The FDA’s announcement pointed to clinical data showing success rates comparable to or better than trained phlebotomists across patients with varying health statuses, difficult vein access, and varying skin tones, which lines up closely with what ADOPT measured, though the FDA didn’t name the trial directly. The authorization is limited to adult outpatients, and it comes with a requirement I think matters more than the headline: Aletta has to operate under the oversight of a supervisor trained in phlebotomy. Vitestro has said commercial rollout will start in Europe, with a phased US launch and an additional US-based multicenter trial to follow before it shows up in American labs at any scale.

Where I land on this

I want to be honest about how reading this study sat with me, because I don’t think I’m the only one in this field who’ll feel it. Part of me is genuinely encouraged. A device that can find a vein reliably in a 70-year-old with difficult access, or a patient with obesity, is solving a real problem. Those are the draws that wear phlebotomists down and wear patients down too, and if the technology holds up outside a controlled trial, that’s worth something, patient safety and satisfaction are important.

The other part of me reads a 94.5% first-stick success rate, comparable adverse event rates, and lower hemolysis than manual draws at the same sites, and I feel something closer to unease. This isn’t a device that’s almost there. The data says it’s already performing in the range of a trained, experienced phlebotomist, on some of the hardest patient populations, in real clinical settings, not a lab demo. That’s a different conversation than the one we were having about robotic phlebotomy even a year or two ago. It seems like every day we hear news about AI or robots replacing people in the workforce, and I don’t want to see that happening to us.

I don’t think this replaces the workforce tomorrow, however. The study itself is single-arm in its larger cohort, industry-funded, and limited to outpatient adults in a handful of hospitals in one country, and Vitestro’s own rollout plans are staged and cautious rather than sweeping. But I can’t call this a “someday” technology anymore either. It’s been sold and used in European hospitals since 2024, it’s now cleared for the US market, and Vitestro is already talking with American hospital systems about bringing it into their labs. The distance between “performed well in a trial” and “in use down the hall” has closed faster than I expected it to.

But closing that distance doesn’t mean one job vanishes, either. The FDA’s authorization requires a phlebotomist to supervise every Aletta in use, with one person overseeing up to three devices at a time. That’s the detail I keep coming back to. Future phlebotomists will require specific machine training. Supervising an autonomous device isn’t the same skill as performing a venipuncture yourself, and it isn’t nothing, either. It means knowing what the device is doing at each step well enough to catch it when something’s off, stepping in the moment a patient is screened out, managing three draws happening at once instead of one, and being the person a nervous patient looks at instead of a machine. Those are skills phlebotomy programs aren’t really teaching yet, and they may need to start.

One place I don’t expect to see this technology any time soon: pediatrics. The trial enrolled patients 16 and older, and every design detail in the published methodology, from the vein-detection process to the patient consent flow, assumes an adult who can hold still, understand instructions, and communicate directly with the device. Kids are a different problem entirely, one that involves fear, movement, small veins, and a level of reassurance that no imaging system delivers. If there’s a corner of this profession that’s insulated from automation for a while yet, pediatric draws are probably it.

I won’t pretend I like the idea of fewer phlebotomy jobs out there. But healthcare is constantly evolving, and new technology keeps showing up whether we’re ready for it or not. We can fight it, or we can adapt to it. Either way, we’re still going to need highly trained, skilled phlebotomists. What’s changing is the shape of that skill set. Soon enough, some of us will be phlebotomists who also know how to manage these machines. That said, this isn’t going to replace inpatient phlebotomists, pediatric phlebotomists, the phlebotomist at your family practice, or mobile phlebotomists, among others. Aletta is designed for high-volume outpatient labs, not those settings. I know changes like this are a little scary when we think about how they might affect us down the road, but it’s better to be aware of them than to be caught off guard.

I’ll be watching for the next round of data, particularly anything that compares the device head-to-head against manual phlebotomy in the same population, rather than against numbers pulled from prior published studies. That’s the comparison that will tell us the most.

Do you have thought on this? Please share what you think in the comments, I’m interested to hear from others.

Subscribe now

Share

Leave a comment

Source: Giesen LFP, Roest JA, Koopman FMA, et al. Performance, Safety, and Patient Experience of an Autonomous Robotic Phlebotomy Device: A Multicenter Trial. Clinical Chemistry. 2026;72(8):845-856. Read the study

Source: U.S. Food and Drug Administration. FDA Authorizes First-Of-Its-Kind Robotic Blood Draw Device. August 19, 2026. Read the announcement

Source: Vitestro. CE marking and European deployment, including the Danish hospital pre-order. Read more

Source: “Aletta: An Update About Vitestro’s Robotic Blood Draw Device,” Phlebotomy Today, on the Northwestern Medicine, Mayo Clinic, and Baylor Scott & White Health trial partnerships. Read the post

That variability is the whole problem with how we teach vein selection in the antecubital fossa. We teach it by name — median cubital first, cephalic second, basilic last — as if the names correspond to fixed, predictable real estate on the arm. They don’t. And if the vein’s position varies as much as the nerve’s does, then “I went for the median cubital” doesn’t actually tell you where the needle went.

The pattern you were taught

Most of us learned the antecubital veins as a simple shape: an H, or sometimes drawn as an M. The cephalic vein runs up the lateral (thumb) side of the antecubital fossa. The basilic vein runs up the medial (pinky) side. Somewhere in the middle, a connecting vessel — the median cubital vein — angles across the fossa and typically links the two.

That’s the textbook picture, and it’s a fine starting point. It’s also where a lot of training stops, which is the problem. The median cubital vein isn’t a fixed landmark sitting neatly in the center of everyone’s arm. It’s a connector, and connectors vary. In some patients it crosses high and lateral, closer to cephalic territory. In others it dips low and drifts medially, tracking closer to where the basilic vein and the structures underneath it live. Cadaveric and ultrasound studies on antecubital venous patterns consistently show this: the “M” shape, the “H” shape, and outright absence of a median cubital connector at all are all documented variants, not exceptions.

Where the CLSI guidance actually splits the arm

CLSI doesn’t rank these veins by name alone — it ranks them by region, and the region lines are drawn down the middle of the fossa. The guidance groups veins into a median/middle zone (the median cubital vein, in its typical position) as the first choice, a lateral/outer zone — the cephalic vein — as the second choice, and a medial/inner zone — the basilic vein, along with the medial aspect of the median cubital vein — as the region to avoid unless nothing else is available.

Read that last part again: the medial aspect of the median cubital vein. CLSI already anticipates that the median cubital vein doesn’t always stay in “acceptable” territory. The standard isn’t naming the vein safe. It’s naming the territory safe, and the vein only counts as a good choice when it’s actually sitting in that territory.

That’s the gap I see trip people up, in training and in the record review I do for litigation. A phlebotomist palpates a vessel, it’s the one they may have been taught to go for first, they call it the median cubital — and they’re not wrong about the vein’s identity. But identity isn’t the same as position. If that same vessel has crossed medially before it reaches the point of insertion, going for “the median cubital” can put the needle in exactly the zone CLSI is telling you to avoid.

Why that zone matters

The reason the outer medial edge gets flagged isn’t arbitrary. One misconception I see a lot: people picture the brachial artery running along the medial edge of the arm. In most patients it actually sits closer to the middle of the fossa, just medial to the biceps tendon — you can usually feel the pulse right next to that tendon if you palpate for it. It’s not glued to that position either; in some patients it runs more laterally, or closer to the surface than you’d expect. The median nerve runs close alongside it — close enough that the separation between them, per that ultrasound data I mentioned, can be under 3mm in some patients. There’s no way to know from the surface which end of that range you’re dealing with. A vein sitting in that territory is sitting near structures that don’t forgive a probing or redirected needle the way a stick in the median or lateral fossa generally does.

This is also why the basilic vein gets labeled last resort, and why that label is correct — but it’s incomplete if the only thing you’re taught to avoid is a vein with that specific name. The risk isn’t the name “basilic.” The risk is the medial position. A median cubital vein that has drifted into that same position carries the same risk, whether or not it’s still technically called median cubital.

This isn’t a hypothetical concern. The vast majority of the nerve injury cases I see in my expert witness work involve a venipuncture in the medial aspect of the antecubital fossa. I’ve also seen several arterial injury cases from punctures in that same area. And in every one of those cases, there were other, safer veins available elsewhere in the AC that went unused. The reason the medial vein got chosen so often isn’t recklessness — it’s that veins in that area tend to be the most prominent ones on the arm. The joint underneath pushes them closer to the surface, which makes them easy to see and easy to feel. Prominence gets mistaken for a good choice, when it’s really just visibility. Both the artery and the nerve may be lurking much closer than you would expect. But prominence doesn’t mean it’s the right choice — that still takes careful decision-making and knowing the anatomy underneath.

What this means at the bedside

None of this means you need to memorize a millimeter cutoff, because there isn’t one — the whole point of the variability data is that a fixed number would be false precision. What it does mean is that vein selection has to be a position judgment, not a name lookup. Before you commit to a site, you’re not just asking “which vein is this.” You’re asking “where on the arm am I, relative to the middle.” A vessel can earn the label median cubital and still be sitting closer to the medial danger zone than a textbook diagram would suggest.

Practically, that comes down to a few habits that should already be part of a good survey: palpate before you stick, and pay attention to how far medially the vessel runs, not just what you’d call it. If a vein you’d normally call median cubital is tracking noticeably toward the medial side of the fossa, treat it with the same caution you’d give a basilic stick — because anatomically, it may as well be one.

The names are useful shorthand. They’re not a safety guarantee. The map most of us were taught treats the antecubital fossa like it’s the same in every patient, and the anatomy simply doesn’t cooperate with that. Knowing where you are matters more than knowing what to call it.

Looking for some super awesome educational phlebotomy posters for your classroom or clinic? Look no further. We have six available in a set or individually. Check them out here.

Subscribe now

Share

Leave a comment

Sources: Ye et al., “Ultrasound assessment of median nerve to brachial artery distance,” Muscle & Nerve, 2026; Shields et al., “Median nerve palsy following venipuncture,” Case Reports in Neurology, 2021; CLSI PRE02, Venous Blood Specimen Collection.

I’ve written before about bloodletting’s ancient roots and the tools that came out of that era, so I won’t retread it here. What I want to focus on is something narrower and, I think, more interesting: the actual devices used to puncture skin, how they changed, and how one of the oldest, crudest designs is still sitting on shelves today — just not in a lab.

The Spring Lancet: Engineering Enters the Picture

For centuries, opening a vein meant a thumb lancet or a fleam — a blade controlled entirely by the steadiness of the operator’s hand. The cut’s depth and length depended on skill, which meant results were wildly inconsistent from one practitioner to the next.

That changed around 1719, when German surgeon Lorenz Heister described a spring-loaded lancet: a blade held under tension that snapped out and retracted on its own when triggered. For the first time, depth could be controlled by adjusting spring pressure rather than by a physician’s hand. It also meant someone with less training could perform venesection with a reasonably consistent result — an early example of a tool doing the precision work that used to depend entirely on operator skill.

Not long after, in the early 1700s, the scarificator showed up — a small brass or steel box housing multiple spring-loaded blades that fired at once, making several parallel cuts in a single action. If one blade was good, the thinking went, twelve were better. It’s a strange-looking object by today’s standards, but it tells you something true about the era: the goal was volume. Nobody was trying to get a “sample.” They were trying to get blood out, and a lot of it.

The scarificator didn’t replace the lancet — the two coexisted for well over a century — but it got used constantly, especially paired with cupping, where a heated cup placed over the fresh cuts created suction to draw more blood to the surface. It also solved a real problem: instead of a physician making repeated cuts with a lancet, one press of a lever produced a uniform set of parallel incisions at a controlled depth. Scarificators only grew more popular through the late 1700s and into the 1800s, hitting their peak of use and sophistication right alongside bloodletting’s own peak in popularity that century.

The Pivot: When Bleeding Stopped Being the Point

Bloodletting’s decline in the mid-to-late 1800s wasn’t instant, but the reasoning behind it eventually caved under the weight of germ theory and a better understanding of physiology and immune response. Once medicine stopped believing that draining blood cured illness, the entire purpose of puncturing skin flipped. Instead of removing blood therapeutically, clinicians started collecting small amounts of it diagnostically — to look at it, not to get rid of it.

This is really the moment capillary puncture as we know it begins. The volume needed shrank from bowlfuls to drops. And that changes what a good tool looks like.

The Plain Metal Lancet: Cheap, Simple, and Slow to Disappear

In more recent times, some of you may remember performing capillary punctures with a more modern version of a fleam: a flat metal blade held in the fingers, with no spring lancet mechanism involved at all. Even after those more sophisticated devices existed, a huge number of punctures were still being done with something this simple — a bare, pointed piece of metal with no mechanism whatsoever.

No spring, no depth adjuster, no retraction, no built-in stop of any kind. The blade — a thin, fully exposed stainless steel point, commonly 36 gauge — stayed out and exposed the entire time you held it, not just at the moment of puncture. Going by the photo above, the exposed point looks to be roughly 3-4mm, noticeably longer than the 1.5–2 mm depth most modern safety lancets are calibrated to. That’s a lot more length than most people actually need for a fingerstick — it’s the kind of depth that only makes sense for someone with genuinely thick, callused skin, not a default setting for the general population.

With a plain lancet, there was no such thing as “setting” a depth. Depth was a function of how hard and how far you pushed, full stop — which means the design really wasn’t that far removed from the thumb lancet or the fleam centuries earlier. Strip away the manufacturing and you’ve got the same basic idea: nothing to control depth, and the outcome resting entirely on user technique. The spring lancet had already solved that problem for venesection back in the early 1700s. The plain metal lancet just never picked up that fix for capillary punctures — it stayed the cheap, simple option long after more controlled devices existed right alongside it.

And going by the length in the photo above — something closer to an eighth of an inch, and noticeably wider than what a modern safety lancet uses — this wasn’t a device built with restraint in mind. It was unnecessarily long and unnecessarily wide for what most fingersticks actually require. That’s genuinely good for one thing: fast, free-flowing blood. It’s bad for everything else. There was no way to dial it back for a patient who didn’t need that much depth, no way to guard against a slip, and no way to protect the person holding it.

An exposed point with no retraction is a needlestick risk to the healthcare worker every single time it’s used, not just an inconvenience for the patient. And because there was no built-in single-use mechanism forcing disposal, it’s worth wondering whether these were always treated as single-use in practice. Needles were commonly cleaned and reused before disposables became standard — there’s no obvious reason lancets would have been held to a different standard, which raises its own cross-contamination risk entirely separate from the needlestick issue.

What ended their clinical use wasn’t the design becoming obsolete. It was OSHA.

OSHA and the Safety Mandate

In 2000, the Bloodborne Pathogen Standard and the needlestick-safety rules that followed didn’t quietly phase these lancets out the way the scarificator faded once bloodletting stopped making sense. This was a hard regulatory line: an exposed, reusable point posed a needlestick and cross-contamination risk that a multi-patient healthcare setting couldn’t accept. Safety-engineered, single-use, self-retracting lancets became the requirement, not just the recommendation, and the plain metal design was pushed out of clinical settings for good.

But here’s the thing — it didn’t disappear. I recently spotted these same plain metal lancets for sale on Amazon, still marketed for fingerstick use. The reviews go well beyond diabetes testing, too: estheticians using them for extractions, crafters, even people using them to remove splinters.

The tool didn’t stop being useful or stop being sold — it stopped being appropriate for medical settings. OSHA’s rules govern occupational exposure, especially where one device could touch multiple patients. A single person using their own lancet at home is a different risk picture than a phlebotomist working through a patient list. The regulation targeted a use case, not the object itself.

Depth Control and Specialty Devices

Meanwhile, on the clinical side, lancet design kept getting more deliberate. Modern devices offer multiple depth settings for different skin thickness and patient age — pediatric and neonatal lancets are built specifically to minimize tissue damage on smaller, more delicate skin.

Vacuum-assisted lancing devices, tested for forearm sampling, have shown they can pull adequate blood volume with less pain than a standard fingerstick. None of this existed when the goal was simply “make blood come out.” Once the goal became “get just enough, as comfortably as possible,” the engineering followed.

Enter the Laser

Which brings us to the part of the title that probably caught your eye. Laser lancing devices, like the LMT-1000 (HandyRay-Lite), use a pulsed erbium-YAG laser instead of a blade to open the skin. Multiple studies comparing laser lancing to conventional lancets for capillary hemoglobin measurement and blood typing found strong correlation in results and significantly lower reported pain scores with the laser — no blade contact at all. It isn’t standard in most clinical labs yet, largely because conventional lancets are still faster and cheaper for routine POC testing, but it’s a real signal of where the field is headed: toward removing pain and mechanical trauma from the equation entirely, not just reducing it.

Not every innovation in this space involves a laser, though. ARUP Laboratories recently partnered with a company called Tasso to offer at-home blood testing built around Tasso’s own collection device. It’s a small device that adheres to the upper arm, releases a tiny spring-loaded lancet that penetrates only about a millimeter, then uses gentle vacuum pressure to draw capillary blood into an attached tube — all without a clinician present. No exposed point at any stage, and a fraction of the puncture depth of even a modern fingerstick lancet.

Between the laser and the vacuum-assisted approach, it’s clear “innovation” in this space isn’t just laser versus blade — it’s also about who can safely perform the puncture and where. Both of these deserve a closer look than I can give them here, so I’ll be covering laser and suction-based lancet devices in a future post. Microneedle arrays and jet-injection devices are being explored for similar reasons, and may be worth a mention there too — ways to get diagnostic blood without a puncture in the traditional sense at all.

The Actual Arc

Line up the whole sequence and the throughline isn’t really about mechanisms — it’s about what we were optimizing for. A bare metal point optimized for nothing but getting blood out fast. The spring lancet optimized for consistency. The scarificator optimized for volume. Once bloodletting gave way to diagnostic sampling, the optimization target flipped completely, and everything since — depth adjusters, pediatric lancets, laser devices — has been in service of one goal: get the smallest useful sample with the least amount of trauma possible.

The plain metal lancet is a good reminder that this shift wasn’t uniform or instant. Old and new tools coexisted for a long time, and even now, a design with roots in centuries-old bloodletting is still available for purchase — just not on a phlebotomy tray.

Looking to start your own phlebotomy school or program? We’ve packaged over 70 of our most essential phlebotomy-program documents, forms, and checklists---proven and perfected in the real world---and are making them available to you to build your own prestigious program. Check them out here.

Subscribe now

Share

Leave a comment

And here’s the thing, being excellent at drawing blood and being able to teach someone else to draw blood are two completely different skills. I’ve watched phenomenal phlebotomists — fast, accurate, calm under pressure — turn into terrible trainers the moment you hand them a new hire. Not because they don’t care, but because nobody ever taught them how to teach. They know what good technique feels like in their own hands. They have no idea how to translate that into words, demonstrations, or patience for someone who doesn’t have it yet.

I once asked someone if I could shadow her for some of her pediatric blood draws. She was known for her ability to draw blood from tiny, dehydrated newborns who were very difficult sticks. I wanted to improve my skills. She was fine with me watching her, and I assumed that she would explain her techniques, her special approach, and give me tips. What I found was that she mostly ignored me, did her job, and didn’t explain her process. If I asked a question about technique, she would tell me to just watch her hands the next time. Sometimes she seemed frustrated with my questions, and I could tell she had a hard time putting her practices into words for me.

I did learn a lot just by watching her, and fortunately she was not overly critical. If she didn’t like what I was doing when it came to my turn she would just take over rather than try to help me. She was not a good teacher. She didn’t know how to share her knowledge other than having me watch, and I could tell that it was stressful for her when I would ask questions. She seemed defensive, rather than eager to answer. It was frustrating for me as well, and left me feeling like a failure when she would take over without any explanation of what I was doing wrong.

So when a lab hands a trainee to whoever’s senior and available that day, they’re gambling with that trainee’s development — and sometimes with their confidence and their future in the profession.

The fix starts before the pairing

If your lab is serious about training new phlebotomists well, the selection of a preceptor shouldn’t be based on tenure or how fast someone is at specimen collection or processing. It should be based on whether a manager has actually watched that person train someone before and seen that they’re good at it.

That means observing for things like:

• Do they explain the why behind a correction, not just bark the what?

• Do they stay patient when a trainee misses two or three patients in a row?

• Does their feedback give the trainee something to actually do differently next time, or is it just criticism dressed up as coaching?

• How’s their tone under pressure — with the trainee, and with the patient? Do they offer encouragement along with criticism?

A tech who’s brilliant at their own draws but impatient, dismissive, or vague when trying to teach someone else shouldn’t be put in front of a new hire solo, no matter how good their own numbers are. That’s not a knock on them — it just means training isn’t their strength, and that’s fine. Not everyone needs to be a preceptor. But somebody needs to notice that before a trainee gets handed off to them.

Why this matters more than it looks

This matters even more once you consider the position a new hire is actually in if the pairing turns out badly. Put yourself in their shoes: they’ve been handed to this preceptor by their manager. As far as they can tell, their manager likes and trusts this person enough to put a brand-new employee’s training in their hands. So if the experience is bad — if the preceptor is impatient, dismissive, or offering nothing but criticism — most new hires won’t go to the manager about it. They’ll assume the manager already sees this person as reliable, and that raising a complaint will read as themself as the problem, whether they are being dramatic, thin-skinned, or unable to hack it — especially against someone who’s been there for years and has the manager’s confidence. So they stay quiet, absorb it, and often just quit instead of ever saying a word.

That’s exactly why the vetting has to happen on the front end. A new hire has almost no leverage to fix a bad pairing after the fact. The manager is the only one with the standing and the vantage point to prevent it in the first place — which is one more reason “has this person actually been observed training someone well” can’t be optional.

It also argues for something on the back end: a standard evaluation the trainee fills out about their experience with the preceptor, given to the manager as a matter of routine — not something the trainee has to request or escalate. If it’s just built into how training works, filling it out isn’t “complaining,” it’s just part of the process, which makes trainees far more likely to actually be honest on it. And it gives the manager an ongoing read on how each preceptor is actually doing with real trainees, instead of relying on the preceptor’s own draw numbers or their word for it.

With the right person vetted for the role and a way to catch it if that goes wrong, the harder question becomes what to do in the moment — on the floor, mid-draw, with a patient watching.

Once you’ve got the right person: the real-time tension

Assuming you’ve got a preceptor who actually wants to teach and knows how — there’s still a genuine challenge that comes up on every single draw: what do you do when your trainee is about to make a mistake, and the patient is sitting right there?

Say nothing, and you risk a bad stick, a blown vein, or a safety issue. Correct too bluntly in the moment, and you risk rattling your trainee in front of the patient — which chips away at both their confidence and the patient’s trust in them. Get this wrong repeatedly, and you can do more damage to a trainee’s development than the actual technical mistakes ever would.

Not every mistake needs an in-the-moment correction

Before you say anything, make a quick judgment call: is this a mistake that could hurt the patient or compromise the sample, or is it a technique preference — something they’ll refine naturally after a few more sticks? Only the first category justifies interrupting a live draw. Everything else can wait for the debrief.

How to correct without alarming the patient

When you do need to step in, how you do it matters as much as whether you do it.

• Keep your tone neutral and calm. “Let’s try holding it this way” lands very differently than “No, not like that!” — even though you’re conveying the same correction. Patients pick up on urgency in your voice faster than they pick up on anything technical.

• Use physical redirection along with verbal. A light touch to reposition a hand or adjust an angle, paired with a quiet, calm verbal cue, often corrects the problem without alarming the patient or drawing attention to what’s happening.

• Set up cues in advance. Before the draw, tell your trainee something like, “If I say ‘let’s check the angle,’ that means adjust now.” A prearranged phrase doesn’t sound like a correction to the patient — it sounds like normal conversation.

• Reserve taking over for genuine safety issues. If you do need to finish the draw yourself, do it without narrating the trainee’s failure out loud. Something as simple as “I’ve got this one, watch my angle” keeps the trainee’s standing with the patient intact.

Frame it as teamwork, not a takedown

Whenever possible, make corrections sound like normal collaborative practice rather than a callout. “We always double-check that together” does the same job as “you’re doing that wrong,” without making the trainee feel exposed in front of the person they’re trying to build trust with.

Save the real conversation for after

The floor, mid-draw, with a patient watching, is not the place for substantive feedback — it’s only the place for the minimum correction needed to keep things safe. The real teaching happens afterward.

As soon as you can after the encounter, while it’s still fresh, take a moment with your trainee privately and talk through it. Good debriefs are specific and behavior-focused: “Your insertion speed was excellent that time, but your angle was too steep going into the left AC” teaches something. “Be more careful” does not. And don’t let the debrief turn into a list of everything they did wrong — tell them what they did right, too. New phlebotomists remember the tone of these conversations as much as the content, and a debrief that’s all criticism teaches them to dread feedback instead of seeking it out. Read more about “Mastering the Art of Constructive Criticism” here.

Building the habit

Set expectations with your trainee before you ever start drawing together. Tell them how you’ll handle it if you need to jump in mid-stick, so a correction doesn’t blindside them. Consistency here builds trust — trainees relax and perform better when they know exactly what to expect from you, instead of bracing for public criticism every time a stick doesn’t go perfectly. A trainer should be a supporter, a helper — someone who wants the trainee to succeed.

None of this works if the person doing the training was never actually equipped — or vetted — for the job in the first place. Real-time feedback is a skill. So is choosing who gets to give it.

Have your own dramatic experiences as a trainee or trainer? Feel free to share in the comments.

We are always looking for guest authors to share their stories and experiences with us. If you have a topic you would like to write about or see us cover please reach out. Thanks for reading!

Subscribe now

Share

Leave a comment

She wakes up unable to fully feel or move part of her hand.

The team does exactly what you’d expect a good team to do — they investigate the surgery. They review the positioning notes. They check the padding, the table, the anesthesia record, everything about how she was lying during a multi-hour procedure. All of it points toward a positioning-related brachial plexus injury, the kind that’s a recognized, if uncommon, risk of long surgeries.

But that’s not what happened to her.

Someone eventually notices bruising at her elbow crease — from a routine blood draw done before she ever went into the operating room. Nerve conduction studies confirm it: this wasn’t a brachial plexus injury from surgical positioning at all. It was a median nerve injury from the venipuncture itself, hours before the surgery even started. The case report doesn’t identify which vein was used or exactly what caused the bruising and compression — only that bruising was present at the site and that a compression-type injury from bleeding under the skin is a well-documented mechanism for this kind of nerve injury.

That’s also a plausible reason she didn’t notice anything wrong right away: that kind of compression builds gradually as blood collects under the skin, so a deficit from it might not show up the moment the needle goes in — it can take time to press on the nerve hard enough to cause a problem, time she happened to spend under anesthesia and unable to feel it happening. The dramatic, complicated explanation was wrong. The routine blood draw was right.

What a “nerve injury” actually feels like

Let’s pause on what we’re actually talking about, because “nerve injury” sounds abstract until you connect it to something everyone has felt.

You know the feeling of your arm falling asleep — you slept on it wrong, or you had it bent under you too long, and it goes numb and tingly until you shake it out and the feeling comes back in a minute or two. That’s a nerve being compressed temporarily, and it recovers on its own because nothing was actually damaged.

A real nerve injury can start out feeling similar, but the sensations it produces can go well beyond numbness and tingling. Depending on which nerve fibers are affected and how severely, patients describe shooting or electrical pains that travel down the arm, or a burning sensation that doesn’t let up. Some describe it as feeling like the sensation you get when you hit your “funny bone,” except it doesn’t fade — it lingers, or comes back with movement. The type and severity of the injury shapes which of these a patient experiences: a mild compression might produce lingering numbness, while direct trauma to the nerve can produce that sharp, electrical, shooting quality that patients often describe as far more alarming than ordinary numbness.

A venipuncture-related nerve injury is that same mechanism, but with the potential to not just go away. It can happen a few ways:

• Direct trauma — the needle itself nicks, punctures, slices, or severs the nerve on the way to (or instead of) the vein.

• Compression from a hematoma — bleeding under the skin after the draw forms a pocket of blood that presses on the nerve, the same way your body weight compressed your arm while you slept, except this pressure doesn’t go away when you shift positions. It stays until the hematoma resolves, or sometimes longer.

• Stretch or positioning — less common, and not venipuncture-related, but relevant to this post. This can happen in the operating room, or with an unconscious person, where a limb can be held in one position for hours.

The difference between “my arm’s asleep for a minute” and a real nerve injury is duration and severity of pressure. A nerve that’s compressed briefly recovers fully. A nerve that’s compressed hard enough, or long enough — from a needle, from a hematoma, from prolonged positioning — can end up with lasting numbness, weakness, or burning pain that doesn’t resolve on its own. That’s the difference between an inconvenience and an injury that needs medical follow-up.

Why this keeps happening

This isn’t as rare as it sounds. In one study (linked at the bottom of the article), a review of iatrogenic (meaning we caused it) nerve injury claims accepted through a no-fault compensation system found venipuncture ranked as the second-most common documented cause of these injuries in that dataset — behind surgical positioning — with the median nerve most often affected. That’s a reflection of what showed up in accepted compensation claims, not a statement about how often either cause occurs across all surgical and medical care generally. Positioning-related nerve injuries are themselves uncommon overall, even though they show up disproportionately often in claims data. Still, the fact that venipuncture ranked where it did in a real claims review means this isn’t a freak occurrence tucked away in a single case report. It’s a documented, recurring pattern.

The anatomy explains why. At the elbow crease, the median nerve typically runs close to the brachial artery — one ultrasound-based study measured the gap at roughly 1.4 millimeters, the kind of proximity that doesn’t leave much margin for error. A larger ultrasound review of 68 patients found that closeness isn’t a fixed number, though: the separation ranged from as little as 2.5mm (about the width of two stacked quarters) to as much as 26mm (about 1 inch), with about 1 in 10 patients showing more than 12.5mm (about half an inch) of space between the two. What did stay constant was direction — in every one of those 68 patients, the nerve sat medial to the artery, even as the distance between them swung widely.

Textbook diagrams show a fairly standard layout: cephalic vein toward the thumb side, basilic vein toward the pinky side, artery and nerve running together medially near the basilic vein. But the basilic vein’s relationship to the artery isn’t fixed the way the nerve’s is — sometimes the artery sits medial to the vein, sometimes lateral, sometimes almost directly underneath it. So while the nerve is typically on the medial side of the artery, just at a variable distance, the vein you’re actually aiming for can be on either side of it entirely. A vein that looks like it’s sitting in a “safer” spot on one patient might be sitting right on top of the danger zone on the next.

The point is, we don’t know exactly where the nerve is, even when we can pinpoint the artery. It’s usually medial, but everyone’s anatomy is different — it could potentially sit lateral instead. That’s exactly why the medial aspect of the antecubital fossa is to be avoided. There’s no knowing precisely where the nerve sits on a given patient. We just know there’s a nerve here somewhere.

Why the rule doesn’t bend

This is exactly why CLSI’s guidance isn’t “measure a safe distance” or “palpate the artery and use your judgment.” It’s a categorical instruction: CLSI’s PRE02 standard states that veins in the medial aspect of the antecubital area should be off the table entirely unless no other vein offers a confident, safe, successful option for collection.

It would be reasonable to ask why the standard doesn’t just say “stay a finger-width away from the artery” or “palpate first, then decide.” The answer is the anatomy itself. If everyone’s vessels and nerves lined up with the textbook every time, a measured distance or a palpation check might be enough. But because that relationship is genuinely unpredictable from patient to patient, a rule that depends on real-time judgment in a variable landscape isn’t a reliable safeguard. A hard boundary is. CLSI isn’t asking phlebotomists to get better at estimating distances near a nerve and artery — it’s removing the estimate from the equation entirely by taking that whole region off the table when there’s a viable alternative.

That’s also why the case above deserves more than a passing mention as a surgical curiosity. There isn’t enough detail in the report to know what, if anything, went wrong in how the draw was performed. What we do know is that it was a routine draw, done the way thousands are done every day, and the injury happened anyway because of where the needle went, and how the hematoma developed. That’s precisely the scenario a categorical rule is designed to prevent: not the reckless outlier, but a draw that went wrong.

The detail that solved it

What eventually cracked the case wasn’t advanced testing — it was someone noticing a bruise at an elbow crease and asking a question instead of assuming it was unrelated to what was happening in the operating room. The nerve conduction study confirmed what the bruise suggested. But the bruise is what made someone look in the right place at all.

That’s a good habit to carry into daily practice, well beyond this one case: when a patient reports something odd after a draw — tingling, burning, a sensation that doesn’t feel like a normal stick — that report deserves attention, not reassurance that it’s probably nothing. Sometimes it’s the only clue anyone gets.

I don’t know for certain which vein was used in this case — the report doesn’t say, and neither does it say exactly what caused the bruising underneath. But given everything laid out above about where the basilic vein tends to sit relative to the median nerve and brachial artery, if I had to put money on it, that’s where I’d put it. It fits the pattern too well not to suspect it: a vein in that medial territory, in a patient whose anatomy put the nerve close enough for a routine stick to end in a compression injury. I can’t prove that’s what happened here. But it’s exactly the scenario the rest of this piece has been building toward.

But the better goal is never needing that clue in the first place. The median cubital and cephalic veins should be the default choice whenever they’re available, precisely because they sit farther from this neurovascular territory. The basilic vein sits close enough to the artery and nerve, on enough patients, that it should be avoided whenever another option exists — not reached for as a routine alternative. Treating it as a last resort, rather than an equal option on the list, is what actually prevents cases like this one from happening at all.

Subscribe now

Share

Leave a comment

We sell super awesome posters that are perfect for the classroom or workspace. Available individually or as a set. Check them out here!

Source: Shields LB, Sutton B, Iyer VG, Shields CB, Rao AJ. Venipuncture-Related Median Nerve Palsy Disguised as Intraoperative Brachial Plexus Injury. Case Reports in Neurology. 2021 Sep 2;13(2):361–368. doi: 10.1159/000515474. Available at: https://pmc.ncbi.nlm.nih.gov/articles/PMC8255717/

This paper is also the source for the New Zealand no-fault claims review and the Ohnishi ultrasound measurement cited above; both were pulled from within it rather than from separate standalone sources.

Also cited: Ye JY, et al. Ultrasound-Confirmed Median Nerve Pseudoconduction Block due to Anatomical Variation. Muscle & Nerve. 2026. DOI: 10.1002/mus.70285

Someone in a supervisory role had emailed him about the topic, unsure if they should prohibit them or not. After a little consideration, Dan and I came to the same conclusion. False eyelashes shed about the same amount that natural eyelashes do. The risk profile doesn’t really change — what changes is how much of them there is. If blinking your eyes sends a breeze through the room, or threatens to lift you off your feet, then they are too long (lash blindness is real). If they impede your vision or are outrageously long and heavy, then it’s probably wise to consider shortening and lightening them. Keep them reasonable, and you’re not introducing anything new into the collection area that wasn’t already a factor with your own natural eyelashes. Keep in mind that they may be prohibited if you work often in critical areas such as surgical units.

That conversation got me thinking about how much the definition of “professional” in the lab has quietly shifted over the last decade, and how many of us are still operating off a mental checklist that’s twenty years out of date.

The old checklist doesn’t hold up anymore

If you trained in the ‘90s or early 2000s, you probably absorbed a version of professionalism that included: no visible tattoos, no unnatural hair color, minimal jewelry, and a face essentially free of anything more adventurous than mascara. Some of that was genuinely about safety. A lot of it was just aesthetic preference dressed up as a rule.

Tattoos are the clearest example of a norm that’s simply moved on. A generation ago, visible ink on a phlebotomist usually required long sleeves or cover-ups. They might’ve made a supervisor raise an eyebrow, or even caused an applicant to not get the job. Today, tattoos are mainstream enough that most employers have quietly dropped blanket bans, because there’s no clinical relationship between having ink and being competent at finding a vein. A sleeve doesn’t affect your technique, your bedside manner, or your ability to read a requisition correctly.

Where I do think there’s still a legitimate line — not about the ink itself, but about content and coverage. Graphic or offensive imagery in a patient-facing role is a different conversation than “does this person have tattoos.” And in settings with immunocompromised patients or strict barrier precautions, coverage becomes a practical matter, not a moral one. But as a blanket judgment on professionalism? Tattoos don’t belong on that list anymore.

Piercings: same story, with a few extra wrinkles

Facial piercings have followed almost the same arc as tattoos, just a step or two behind. A nose stud or septum ring used to be an automatic red flag on an application. Now it’s common enough that plenty of patients wouldn’t blink, and some genuinely respond better to a phlebotomist who looks a little more like them than to one who looks like she stepped out of a 1998 employee handbook photo. I’ve heard from colleagues who work with a lot of teenage or young adult patients that a visible piercing can actually work in their favor — it reads as approachable rather than clinical and intimidating, especially to a nervous first-time donor or a kid dreading their labs.

That said, this is one area where I’ll tell you flatly: check your facility’s policy before you assume anything, because there’s no industry consensus here. Some hospitals allow a single small nose stud and nothing else. Others ban all visible piercings besides earlobes outright. A few draw the line specifically at tongue piercings, because they can genuinely interfere with speech clarity. None of these policies are wrong, exactly. They’re just different answers to the same question, and your facility’s answer is the one that counts on your shift.

Where I do have a personal opinion, mask fit is the one that actually stops me in my tracks. If a septum ring, nose jewelry, dermal piercings, or anything else keeps your N95 from sealing properly, that’s not a style debate anymore — that’s a fit-test failure, and it doesn’t matter how good it looks. Same logic applies to anything that dangles. A stud is one thing; a piece of jewelry that swings free near a patient’s face is a snag risk the moment you lean in for a draw on a squirmy kid or a startled patient. And like fake nails, an actively inflamed or infected piercing site can be a problem regardless of how small or tasteful the jewelry is — that one’s not up for debate no matter what the dress code says.

So my honest take: piercings are trending the same direction tattoos already went, and I think that’s mostly a good thing. But “more accepted” isn’t the same as “no rules apply.” Small, secure, and mask-compatible wins every time. Follow your facility’s policy first, use your own judgment second.

A quick word on hair color

I’d be remiss not to mention hair color, because it’s the one item on this list with no clinical angle at all. There’s no infection risk, no mask-fit issue, nothing to disinfect — it’s purely about image, which makes it the most subjective line on the whole list.

And the trend line is genuinely moving. Some hospital systems have gone as far as stripping “no unnatural hair color” language out of their dress code entirely, right alongside their old tattoo restrictions, in favor of a shorter, values-based policy instead of a rulebook trying to anticipate every possible shade. Other facilities haven’t budged an inch and still name specific colors — blue, green — as simply not appropriate for a professional setting. There’s no consensus here, and unlike nails, there isn’t going to be one, because there’s no research to eventually settle it one way or the other.

So this one really does come down to your facility and your patient population. A pop of color might build instant rapport with a nervous pediatric patient and be a complete non-issue with a younger adult population, while the same color might read as less put-together to an older patient base that grew up with a stricter idea of “professional.” Neither reaction is wrong — it’s just a real variable worth thinking about, not a rule I’d try to hand down universally the way I would with nails. That being said, it’s always safe and professional to stick to more natural hair colors.

Claws for Concern

Here’s where I’ll part ways with the “everything’s fine now” crowd: acrylic and gel nails. This isn’t a style opinion — it’s an infection control issue, and it’s one of the few grooming questions in this whole conversation that has real evidence behind it rather than just changing taste.

I know there’s a growing chorus online arguing that the artificial-nail rule is outdated, overly rigid, or just another way workplaces police appearance instead of actual competence. I get where that frustration comes from — plenty of dress-code rules really are more about tradition than safety. But when I went looking for anything that would justify walking this one back, I didn’t find it.

The evidence hasn’t moved. CDC hand hygiene guidance still tells healthcare workers not to wear artificial nails or extenders (Gel-X, press-ons, false tips, etc.), and it’s not a soft suggestion — it’s one of their highest-confidence recommendations, the kind reserved for practices backed by solid, well-designed research. The WHO’s position is even broader, flagging artificial nails as a hand hygiene risk for every healthcare worker, not just those working with high-risk patients. And this isn’t theoretical: specific outbreaks have been traced directly back to staff wearing artificial nails, including a NICU cluster and a bone infection outbreak linked to acrylics. What I think is actually happening online is a compliance problem getting mistaken for a policy problem — plenty of facilities have the rule on the books and still don’t enforce it consistently, which makes it feel optional. It isn’t. The rule hasn’t softened; the follow-through has.

And it’s not just the “fake” part that matters — length counts just as much, on natural nails or otherwise. The same rationale that keeps acrylics off the table also caps how long your own nails can be, typically to about a quarter inch past the fingertip. Long nails, real or false, make it harder to get a hand truly clean, they’re more likely to tear a glove mid-draw, they can scratch a patient during positioning, and they can make palpating and handling equipment difficult. So my stance isn’t just “no acrylics” — it’s no long nails, period, regardless of what’s growing them.

Artificial nails are also harder to disinfect than natural ones. They can harbor bacteria underneath the nail bed even after proper handwashing, they’re more prone to developing tiny cracks and chips that trap organic material, and they increase the odds of an accidental glove puncture during a draw. None of that has anything to do with fashion — it’s a hand hygiene problem with a manicure attached to it. So while lashes and tattoos get a pass from me, and piercings are trending toward acceptance, fake nails and long nails still don’t. That’s not old-fashioned thinking; it’s the same reasoning that keeps nail polish restricted to short, chip-free coats, or nothing, in most healthcare settings.

Think about what that actually looks like on shift. MRSA trapped beneath your lifting 10-day-old gel nails can transfer to everything you touch — the tourniquets and gauze you stocked that will go directly on the patient’s arm, the blood culture bottles you pulled out for the elderly patient with a fever, or the lancet you need for a newborn heel stick. It’s not an abstract risk sitting under your nail; it’s riding along with you to the next patient, and the one after that.

Polished, not permitted

Put tattoos, piercings, and lashes together, and where does “professionalism” actually live now? I’d argue it’s less about a checklist of prohibited items and more about one simple word: polished.

Polished isn’t the same thing as conservative. It’s the difference between a phlebotomist who walks in with wrinkled scrubs, a stained lab coat, and hair that hasn’t seen a brush since yesterday’s shift — versus one who’s got visible tattoos, a nose stud, and a full lash set, but their scrubs are clean and fitted, their hair is pulled back and out of the draw site, their badge is visible, and they move with the kind of quiet confidence that tells a patient “I’ve done this a thousand times and I’m about to do it well.”

Patients decide whether they trust you in about the time it takes you to say hello. That judgment happens before you’ve demonstrated a single bit of technique. It’s made almost entirely on how put-together you look and how you carry yourself. A patient isn’t scanning for ink, piercing placement, or lash length — they’re scanning for whether you look like you know what you’re doing. Sloppy reads as careless. Careless is the thing that actually erodes trust, not a tattoo sleeve or a septum ring.

Where I land

Tattoos: a non-issue, with common-sense limits on content and coverage in specific clinical settings. Piercings: increasingly accepted and, for some patients, actually a point of connection — but this is the one area where your facility’s policy is the final word, and mask fit, snag risk, and active infections are non-negotiable regardless of what the handbook says. Hair color: no clinical case either way, so it’s purely a facility-and-patient-population call, not a rule I’d hand down universally. False eyelashes: fine, as long as they’re not so long or heavy that they become a distraction or a genuinely different physical presence in the collection area than your own lashes would be. Fake nails and long nails, real or artificial: still a no, and the evidence behind that hasn’t gone anywhere, whatever the online pushback sounds like — it’s about what’s living under a nail that a hand wash or even a scrub sink can’t reliably get to.

Professionalism in 2026 isn’t about looking like it’s 1985. It’s about looking — and acting — like someone this patient, in this exact moment, would trust with their vein. Ink, piercings, lashes, and hair color don’t threaten that. Cleanliness, preparedness, and confidence build it. And a set of acrylics — or just plain long nails — under your gloves quietly works against it, whether or not anyone in the room can see them.

Looking for training videos for students or staff? Check out our Applied Phlebotomy Series that covers the critical topics people need to know. Available for streaming or on DVD.

Subscribe now

Share

Leave a comment

I want to walk through where OSHA’s Bloodborne Pathogen Standard came from, because understanding the fear and the fight behind it changes how you see the routine safety habits we now barely think about.

The world before the rule

Picture a clinical setting in the early 1980s. Needles got recapped by hand, routinely, without a second thought. Gloves were something you reached for if you happened to have a visible cut on your hand, not something you put on for every single draw. Blood was blood — nobody was treating it like a hazardous material because, as far as anyone knew, it mostly wasn’t one.

That world wasn’t reckless by the standards of the time. It was just uninformed. And then everything changed.

Narrow that picture down to the blood draw specifically, and it gets even starker. Phlebotomists were doing venipunctures without gloves as a matter of routine, not exception. Used needles got recapped by hand between patients, which meant the exact moment a stick was most likely to happen was a moment nobody thought twice about. There was no standardized expectation that a used needle went straight into a dedicated sharps container — plenty ended up back on a tray, in a pocket, wherever was convenient until disposal. If you draw blood for a living today, that’s the job your predecessors were doing, with the tools they had and the knowledge available to them at the time.

AIDS turns a known risk into a national crisis

Every time I dig into the history behind a major shift in phlebotomy practice, I end up back at the same starting point. Hepatitis B had already been recognized as an occupational hazard for healthcare workers for years by this point, but it hadn’t been enough, on its own, to force sweeping federal regulation. What did force it was the emergence of HIV and AIDS in the early 1980s.

As the epidemic spread and the medical community came to understand that HIV could be transmitted through blood exposure, fear moved through hospitals and clinics fast. Healthcare workers were afraid of contracting a disease that, at the time, was a death sentence with no treatment in sight. That fear translated into real pressure — from nurses, from physicians, from unions, from the public — demanding that something be done to protect the people whose job put them in daily contact with blood.

The CDC moves first: Universal Precautions

Before OSHA ever finalized a binding rule, the CDC introduced a concept in the mid-1980s that would end up reshaping clinical practice permanently: Universal Precautions. The idea was simple but radical for the time — treat all blood and certain body fluids as if they are infectious, regardless of whose they are or what you know about the patient.

This is the direct ancestor of the instinct you have today to glove up for every single draw, no exceptions, no judgment calls based on how a patient looks or what’s in their chart. Universal Precautions came first as guidance. OSHA’s job was to turn that guidance into enforceable law.

Getting the rule written was its own battle

OSHA didn’t just write this standard quietly in a back office. The proposed rule went through a genuinely public fight. The agency received roughly 3,000 public comments, largely from the medical and dental communities, and held five public hearings across the country — in Washington D.C., Chicago, New York City, Miami, and San Francisco. All told, 440 individuals and organizations showed up to testify.

Congress got involved too, and not gently. Lawmakers attached a rider to OSHA’s fiscal year 1992 funding bill that forced the agency’s hand, requiring the Bloodborne Pathogens Standard to be finalized by December 1, 1991. During the debate over that rider, members of Congress made the case plainly: the risk to workers was too serious, and the possibility of preventable illness and death could no longer be pushed down the road.

Stop and consider how all of this actually came together. There was no social media to rally people overnight, no viral post to put pressure on lawmakers within hours. Getting thousands of comments filed, hundreds of people to show up and testify in five different cities, and Congress to act with real urgency took old-fashioned organizing — phone calls, mailed letters, professional associations mobilizing their members, one person at a time. That this moved as fast as it did, without any of the tools we take for granted now, says a lot about how seriously people understood the stakes to be.

December 6, 1991: the standard is born

OSHA missed the congressional deadline by five days, publishing the final Occupational Exposure to Bloodborne Pathogens Standard — 29 CFR 1910.1030 — on December 6, 1991.

The numbers behind that urgency say a lot about why this wasn’t bureaucratic overreach. In 1990, OSHA had estimated that occupational exposure to bloodborne pathogens was causing more than 200 deaths and 9,000 new infections every single year. That’s not an abstract policy problem. That’s thousands of healthcare workers getting sick, and hundreds dying, from doing their jobs.

What the standard actually demanded

The rule required employers to build a real exposure control plan, not just a policy binder that sat on a shelf. It mandated engineering and work practice controls, required personal protective equipment, and — critically — required employers to offer the hepatitis B vaccine free of charge to any employee at risk of occupational exposure. It also laid out specific requirements for what had to happen after an exposure occurred: evaluation, follow-up, documentation, all of it.

If any of that sounds familiar, it should. This is the scaffolding underneath nearly every safety protocol you follow on the job, and the reason your facility has a documented process for what happens if you get stuck.

The rule kept evolving: safer needles enter the picture

The standard wasn’t frozen in 1991. In 2000, Congress passed the Needlestick Safety and Prevention Act, which required OSHA to revise the Bloodborne Pathogens Standard specifically to address the use of safer needle devices. That revision took effect in 2001.

This is the direct reason safety-engineered devices — needles with retractable or shielded mechanisms — became standard equipment rather than an optional upgrade. If you’ve ever used a device that clicks a shield into place the moment you withdraw it from a vein, you’re using the product of this specific piece of legislation.

Did it actually work?

The standard has teeth, and OSHA has used them. Between 1991 and 2015, OSHA issued more than 77,000 citations for noncompliance with the Bloodborne Pathogens Standard, most commonly for gaps in exposure control plans and recordkeeping. That’s not a rule collecting dust — it’s one that’s actively enforced, more than three decades after it was written.

And it still gets enforced today. OSHA continues to conduct routine and complaint-driven inspections of healthcare facilities, and continues to hand out fines when it finds violations. That should tell you something important: this isn’t a solved problem. Facilities still get cited for missing or outdated exposure control plans, incomplete sharps injury logs, and PPE that isn’t actually available where and when workers need it.

Part of why the enforcement never stops is that the pressure to cut corners never stops either. Safety-engineered devices cost more than standard ones. Adequate PPE supplies cost more than skimping. Training takes time away from patient volume. Every so often, somewhere along the chain — a facility trying to trim its budget, a purchasing department choosing the cheaper non-safety needle, a worker who’s been told to move faster and starts skipping steps — someone decides the rule is optional. It isn’t. That’s exactly why the standard still needs teeth more than three decades later.

Why this history matters to you

Most phlebotomy students today have never lived in a world without gloves-as-default, without sharps containers, without a documented exposure protocol. That’s exactly the point. The standard did its job well enough that the crisis it was built to solve is no longer visible to the people benefiting from it every day.

But it came from somewhere. It came from a terrifying epidemic, from healthcare workers who were scared and said so loudly, from public hearings and congressional pressure and a regulatory process that took years to get right. Knowing that doesn’t just make for a good history lesson — it gives you a reason for every glove, every sharps container, and every exposure protocol that isn’t “because the rules say so.”

Next time you glove up without thinking about it, give yourself a second to remember that just 30 short years ago, it wasn’t always automatic.

Looking for something to add to your phlebotomy resources? Culled from the thousands of questions we’ve been asked over the years, this reference book is a must-have for anyone who performs, teaches, trains, or supervises phlebotomy. Each answer is highly researched and reflects the current standards, guidelines, and published literature. The Lab Draw Answer Book is a great gift for anyone!

Subscribe now

Share

Leave a comment

It’s a fair complaint, and honestly, I understand where it comes from. If a new hire’s angle of insertion is off, or they’re fumbling the order of draw, that’s correctable with a little coaching and repetition. But if a new hire can’t hold a normal conversation with a patient, freezes up when asked an unexpected question, or doesn’t read the room well enough to know when someone’s uncomfortable — that’s a much harder thing to train into an adult after they’ve already been hired. By the time they’re standing in front of a real patient in a real facility, we’ve had our shot at teaching what we can. So the real question is: are we using that shot on the right things?

The Problem: Comfortable Isn’t the Same as Professional

If you teach phlebotomy, you already know what happens in a classroom full of students practicing on each other. They get comfortable fast. They joke around, they relax, they stop being nervous about needles so much, and start having a lot more fun. In a lot of ways, that’s exactly what you want — confidence and comfort with the procedure are the whole point of hands-on practice.

But there’s a side effect. Comfort with each other doesn’t automatically translate into professionalism with a stranger. If your students only ever practice in “friend mode,” that’s the only mode they’ll have muscle memory for. And it gets worse when they practice on people they’re already close to — a sibling, a spouse, a volunteer they know well. Familiarity invites shortcuts. The patient says “ouch,” and the natural relationship response is “you’re fine” — which is a perfectly normal thing to say to your brother, and a completely wrong thing to say to a patient you’ve never met.

The fix isn’t eliminating casual peer practice — it’s valuable, and it builds real comfort with the physical skill. The fix is making sure students also get dedicated, structured time where they’re expected to be a perfect professional, and making the difference between those two modes explicit instead of assumed.

On easy practice days where the focus is on basic skills and getting as many draws done as possible, professionalism is less of a focus — though of course good behavior is still expected. Then there are other times, once a student has gotten the hang of how to do a blood draw, where we can layer in the additional factors: chatting throughout the draw, checking on the patient, and working deliberately on professionalism.

Teach the Switch, Not Just the Skill

I like framing this to students as two settings they need to be able to name and recognize in themselves: practice mode and performance mode. Practice mode is where the relaxed, joking-around version of them lives, and it’s fine there. Performance mode is where the professional lives, and it needs to switch on the moment a “patient” — real or simulated — is in the chair.

This is where scripted scenario work earns its place in a curriculum. Give students a bank of the kinds of odd, uncomfortable, or pointed questions patients actually ask:

• “Can I keep a vial of my own blood?”

• “You seem awfully young — do you have enough experience to be doing this?”

• “I’m a hard stick. You only get one try and then I want your most experienced person.”

• “Can I poke myself? I’m the only one who can get my own veins.”

• “What do you guys do with the blood when you’re done with it?”

The standard isn’t that they need a perfect answer every time. The standard is that they answer well, or they say “I don’t know, let me find out for you” and follow through — never freeze, never get flustered, never get defensive. That’s the actual skill. Confidence under an unexpected question is professionalism, and it’s just as trainable as venipuncture technique if you drill it the same way.

During supervised draws on the days you’re focused on this, hold students to the full soft-skills checklist, not just the technical one:

• Greet the patient warmly

• Check in on them more than once during the draw

• Make easy conversation — weather, upcoming holidays, nothing heavy

• Ask how they’re doing before stepping away

• Address any concerns the patient raises, like bruising or lingering soreness

• Let them know they can call with any questions or concerns

And when a student gets so locked in on the mechanics of the draw that they forget there’s a person attached to the arm, that’s your moment to jump in. I’ll prompt students mid-poke to actually look at the patient’s face, read their body language, and say something as simple as “you’re doing great, almost done.” It sounds small. It’s not. It’s the difference between a technician and a professional.

The most important thing to communicate to students about all of this: it is not a “do it a couple of times and you’ve got it” skill. It’s a “practice this way until it’s easy and habitual” skill, same as any other repetition-based competency we teach. Soft skills decay without repetition just like technical skills do — the only difference is we tend to give technique a hundred repetitions and professionalism a little less.

Debrief Every Draw — Not Just the Technique

That switch has to get exercised somewhere besides the draw itself, and the best place I’ve found is right after it. One of the most useful habits I built into supervised practice was a short debrief immediately after each draw.

Right after the student finishes the venipuncture, I ask them two questions: What do you think went well? What do you think you could work on next time? Let them answer first, before you say anything. Making a habit of this teaches students to size up their own performance honestly instead of waiting for someone else to hand them a verdict — and a 2024 NACE survey found that professionalism is one of the widest gaps between how new graduates rate themselves and how the employers hiring them do. The debrief habit also hands you a natural, low-friction opening to praise and correct in the same breath, which lands better than either one alone.

This is also where you fold the soft-skills checklist into the technical one, in the same sentence: “Your technique was clean, tourniquet was nice and tight, that’s great — now let’s talk about your speed, and remember to check on the patient a couple of times throughout the draw, not just at the end.” Students hear the win and the growth area back to back, attached to a specific, recent memory of what they just did. That combination — genuine credit plus a specific, actionable note — is what actually changes behavior over time. A vague “good job” changes nothing. Neither does a list of only what went wrong.

Zero Tolerance for Casual Language

The switch shows up in language too, and it’s one place I’ve watched it slip further than almost anywhere else. Here’s something I’ve noticed shift over the last decade or so: casual profanity between students in the classroom. It didn’t used to be common to hear, and now it’s not unusual to hear an “F-bomb” dropped between students like it’s nothing.

This needs to be shut down immediately, every time, without exception. It’s not appropriate for the workplace, and it’s not appropriate for the classroom that’s supposed to be preparing students for the workplace. The way I frame it for students isn’t “watch your language because I said so” — it’s the same practice-mode/performance-mode switch from earlier.

There’s a difference between “daily language” and “workplace language,” and part of professional development is learning to live in workplace language the moment you walk through the door, not just when a patient’s in the room. The moment someone enters a professional space, even if they’re working alongside people who become friends, they need to maintain a professional demeanor and use appropriate language.

The Gen Z Stare Is Real

Language is only half of what’s flattened out in the last few years — the nonverbal side has too. You ask a question, and instead of a nod, a “mhm,” or raised eyebrows, you get a flat, silent stare back. It’s been nicknamed the “Gen Z stare,” and whatever you think of the label, the underlying pattern is real, and it matters a lot in a patient-facing job.

A blank expression reads to a patient as disinterest or incompetence, even when the technical draw underneath it is flawless. Things that used to be safe assumptions — smile at the patient, make eye contact, carry a bit of small talk — now need to be taught explicitly and drilled like any other skill, because a growing number of students are arriving in class without that practice already built in.

There’s a reason for that. This generation has grown up with more of their social interaction mediated through screens than any before them, and a 2024 Pew Research survey found teens are more likely to say smartphones make it harder to learn good social skills than easier — 42% versus 30%. That lines up with something a lot of us have noticed anecdotally long before we saw it in a report: this generation needs more explicit practice at basic human interaction than we used to have to give, not because they’re unwilling, but because they’ve had fewer natural opportunities to build it before they ever got to us. Which brings us back to the same principle running through this whole post — if it isn’t automatic anymore, it has to be taught on purpose.

Grading the Intangible

All of this raises the obvious follow-up question: how do you put a grade on any of it? “Professionalism” feels too subjective to score fairly, so it’s tempting to either skip grading it altogether or reduce it to a single vague line item that doesn’t really measure anything.

A few things that have actually worked for me:

Grade observable behaviors, not vibes. You can’t reliably grade “good attitude.” You can absolutely grade a checklist: greeted patient by name (yes/no), made eye contact at greeting (yes/no), checked in with patient at least twice during draw (yes/no), asked how they’re feeling before leaving. Add these up across a few supervised draws and you have something defensible.

Track consistency over time, not a single performance. One graded observation is a snapshot. A running log across multiple sessions tells you whether professional behavior is becoming habitual — which is the entire goal — or whether it only shows up when they know they’re being watched.

Use scripted scenarios as a rubric, not just a drill. Hand the “patient” a note card with a couple of odd or pointed questions or statements to work into the encounter, and have the student practice responding in the moment. Each one can carry a simple three-point scale: acknowledged the question appropriately, gave a correct answer or deferred appropriately, maintained composure and warmth throughout.

Weight the debrief conversation itself. A student’s ability to accurately name their own strengths and growth areas in the post-draw debrief is a skill worth grading on its own — it’s the same self-awareness gap NACE keeps flagging, and it’s something that really pays for itself over time.

None of this will ever be as clean as grading whether a tube filled correctly. That’s fine. The goal isn’t false precision — it’s making sure “professionalism” in your gradebook means something specific enough that a student can actually improve on it, instead of just feeling bad or good about a number they don’t understand.

Send Them Out Ready

Employers aren’t wrong that professionalism is the hardest thing to fix after the fact. But that’s an argument for teaching it more deliberately in the classroom, not an argument that it can’t be taught at all. Give students an explicit switch to flip between casual and professional. Drill the hard questions the same way you drill technique. Debrief every draw so students build the habit of honest self-assessment alongside the habit of a clean venipuncture. Hold a hard line on language. Recognize the changes in social behavior in these younger generations. And grade what you can actually observe, consistently, over time.

We can’t hand employers a finished professional. But we can hand them a student who’s had real, repeated practice at being one — not just a student who was comfortable in a room full of friends.

What’s worked for you in teaching professionalism? I’d love to hear your strategies in the comments.

Subscribe now

Share

Leave a comment

Check out a couple of our professionalism related products: To the Point Article - When Professionals Aren’t. This article discusses unprofessional behavior and the impression it gives to patients. And a Phlebotomy Continuing Education Exercise (ATM): Customer Service Excellence. Discusses the behaviors that promote good customer loyalty and those that destroy it.

First, an apology for missing last week’s post. I was traveling to Virginia for the ASCP Virginia Chapter Phlebotomy Seminar, where I had the privilege of speaking — and unfortunately, the hotel had other plans when it came to internet access.

It was an incredible experience. To the organizers who put the seminar together and to everyone who attended — thank you. Virginia, it turns out, is home to a remarkable concentration of people who have made lasting contributions to the phlebotomy and laboratory world, and I feel lucky to have finally met some of them in person. I left inspired, and I hope it won’t be my last time there.

Early in my hospital career, I had orders to collect blood samples from a newborn who had been brought to the ED. I was running behind, and by the time I entered the infant’s room a nurse had decided she didn’t want to wait for me and she was going to attempt to collect the blood herself. I walked into the room to find the nurse preparing to place a peripheral IV on the infant. The doctor had ordered a bilirubin and a CBC — two tests, both routine, both very doable from a heel stick. I asked if she’d considered capillary collection instead. She paused, looked at the baby, looked at me, and said, “Oh. Yeah. I always forget we can do that.”

We did the heel stick. The baby cried for about thirty seconds. No IV, no catheter dwelling in a tiny vein, no tape on a fragile arm. Just a small lancet wound on the lateral heel, two microcollection tubes. Done. The infant ended up being okay, just a fussy newborn with a mild fever and nervous parents.

That moment stuck with me — not because the nurse was wrong or incompetent, but because it revealed something true about how we sometimes default to the most invasive option out of habit. That infant didn’t need an IV, or a venipuncture for two small samples. Why not see what the labs say before placing a potentially unnecessary IV in a tiny newborn arm? The more invasive option is still available if needed. The nurse didn’t think of it, and she didn’t know how to perform it properly, but once I reminded her of the option, she was all for assisting me in trying that first.

That being said, capillary collection is its own skill set, with its own indications, its own limitations, and its own quirks. And one of the biggest quirks is this: the numbers don’t always match venous results. Sometimes it’s a great option, sometimes it’s better to obtain venous blood — not because someone made a mistake, but because capillary and venous blood are genuinely different things.

They’re Not the Same Blood

This surprises a lot of people, including experienced healthcare providers. We tend to think of blood as blood — same patient, same body, same values. But what comes out of a fingerstick or a heel stick isn’t purely venous or purely arterial. Capillary blood is a mixture: arterial blood delivered through the capillary bed, venous blood returning from the tissues, and small amounts of interstitial and intracellular fluid that inevitably get drawn in during collection.

That mixture, under ideal collection conditions, tends to be closer to arterial blood in composition — which is why warmed capillary specimens are sometimes called “arterialized.” But ideal conditions don’t always happen. Technique errors, patient factors, and the basic physiology of the capillary bed can shift that composition significantly. The result is a specimen that looks a lot like venous blood in some analytes and nothing like it in others.

Understanding which analytes behave which way — and why — is the difference between a phlebotomist who just collects the specimen and one who understands what they’re actually collecting.

The Analytes That Don’t Always Agree

Glucose

Glucose is the analyte most people already know behaves differently by collection method, but they don’t always know why or by how much.

In a fasting state, capillary and venous glucose values are fairly close — usually within a few mg/dL of each other. But after a meal, the arteriovenous difference opens up significantly. Capillary glucose can run 20–70 mg/dL higher than venous glucose in the postprandial state because glucose is being actively delivered to the tissues via the arterial circulation and hasn’t yet been extracted. A capillary draw catches that glucose before the tissues have had their cut.

This matters clinically in a few ways. First, most point-of-care glucometers are calibrated for capillary whole blood — using a venous sample on a capillary-calibrated device can produce inaccurate results, and some analyzers will flag this. Second, a capillary glucose and a venous glucose drawn close together on the same patient may look like a discrepancy when they’re actually both correct. The collection method needs to be documented.

Hemoglobin A1c

A1c is worth addressing specifically because it’s increasingly being run on point-of-care analyzers from fingerstick samples. For most patients, capillary A1c correlates well with venous A1c — the hemoglobin being measured has been circulating for weeks, so the arteriovenous mixing effect matters less than it does for real-time analytes like glucose.

The complication is technique. Hemolysis and specimen dilution from poor capillary collection technique can affect A1c results, particularly on HPLC-based analyzers. Some POC A1c platforms have been validated specifically for capillary collection; others have not. If your facility is running A1c from a fingerstick, it’s worth knowing which platform you’re using and whether capillary collection has been included in the method validation.

Potassium

This is the one that makes laboratory professionals nervous, and for good reason.

Capillary potassium runs higher than venous potassium, and the gap can be clinically significant. There are a few reasons for this. Tissue fluid contamination during collection introduces intracellular potassium from disrupted cells. Milking the puncture site — squeezing the finger or heel repeatedly to force blood flow — causes mechanical hemolysis that releases even more intracellular potassium. Cold extremities slow blood flow and increase the likelihood of stasis, which also artificially elevates potassium.

The problem is that a falsely elevated potassium can look like true hyperkalemia. A patient who appears to have a potassium of 6.2 from a fingerstick may have a venous value of 4.8. That false result can trigger unnecessary interventions — cardiac monitoring, medication changes, repeat testing — based on a number that was never real.

If potassium is the reason for the draw, or if the result will drive a clinical decision, capillary collection is generally the wrong choice.

Hematocrit and Hemoglobin

Capillary hematocrit tends to run higher than venous hematocrit, particularly in neonates. There are a few reasons: tissue fluid dilution is smaller relative to the total sample in a well-collected capillary draw, and the arterial component of capillary blood has a higher oxygen saturation and slightly different cellular composition than venous blood.

In newborn screening and neonatal bilirubin workups, this difference is generally understood and accounted for by the reference ranges used. But if a capillary CBC hematocrit is being used to evaluate anemia or polycythemia in an infant, the collection method should be clearly documented and the ordering provider should know the specimen source.

Prothrombin Time (PT/INR)

POC coagulation testing — particularly INR monitoring for patients on warfarin — is increasingly done from fingerstick samples, and this is an area where the evidence is more nuanced than most people realize.

Capillary INR and venous INR generally correlate well in stable, therapeutic patients. Studies have generally found that for patients who are in a steady anticoagulation state, POC fingerstick INR is a clinically acceptable alternative to venous lab INR. However, the correlation weakens at the extremes of the therapeutic range — very high or very low INR values — and in patients who are acutely ill, in shock, or have poor peripheral perfusion. In those situations, the capillary result may not accurately reflect the patient’s true coagulation status.

Again, the key variable is knowing when capillary is appropriate versus when you need a venous draw.

Bilirubin

Transcutaneous and capillary bilirubin measurements in neonates are workhorses of the newborn nursery. For routine hyperbilirubinemia screening in otherwise healthy term neonates, capillary bilirubin is generally reliable and widely used.

Technique matters here more than in almost any other analyte. Specimen exposure to light causes photo-oxidation of bilirubin, which means the tube needs to be protected from light from the moment of collection. A slow fill, a cold heel, and excessive milking can all affect the result. And because bilirubin is one of the primary drivers of clinical decision-making in the first days of life — including decisions about phototherapy — accuracy is non-negotiable.

When Capillary Collection Is the Right Call

None of this is an argument against capillary collection. It has legitimate, well-established indications, and in the right situation, it’s not just acceptable — it’s the better choice.

The clearest example is neonates, because the clinical math is more complicated than it might seem.

When a physician orders a bilirubin and a CBC on an infant, the instinctive response in many clinical settings is to reach for venipuncture supplies. I’ve seen it happen dozens of times. But before going straight to a peripheral blood draw, it’s worth asking: can capillary collection get us what we need?

For a bilirubin and a CBC — two of the most common neonatal orders — the answer is often yes. A proper heel stick using an automated lancet on a warmed heel, collected into microtainers, can yield adequate volume for both tests without puncturing a fragile vein. That matters for a few reasons.

The evidence on pain is more nuanced than you might expect. Several studies have found that skilled venipuncture in newborns is actually less painful than heel stick — particularly when milking is required to get adequate volume. A Cochrane review has suggested venipuncture may be the procedure of choice in term neonates in some contexts. However, the real-world consideration that often tips the balance is this: the heel stick preserves venous access. If the infant ends up needing an IV later — for fluids, antibiotics, or a longer stay — that vein is still there, unused and undamaged. Performing a venipuncture you may not need, on a baby who may go home tomorrow, is a different risk-benefit calculation than placing an IV on an infant who is clearly ill.

That said, venipuncture in a newborn is not without its own risks, and those risks deserve weight in the decision. Neonatal anatomy is unforgiving — veins are small, fragile, and frequently difficult to visualize, and the structures surrounding them are compressed into a much smaller space than in older patients. Nerves, tendons, and arteries run in close proximity to common venipuncture sites, and a newborn cannot tell you that the needle is in the wrong place. Unlike an adult who flinches or says “that burns,” a neonate’s only feedback is crying — which is already happening.

Hematoma formation is a real concern, particularly in premature or jaundiced infants where skin and vessel integrity may already be compromised. Repeated failed attempts cause cumulative tissue trauma, and in a patient whose total blood volume may be as little as 80–90 mL/kg, even minor blood loss from multiple punctures is not trivial. A skilled phlebotomist can do their best to perform a safe venipuncture on a newborn, but those risks will still be there. The heel stick may be the better choice precisely because while it may be more painful, it avoids the risks that come with venipuncture, whether it’s a routine blood draw or IV placement.

This is the conversation worth having at the bedside. Not “heel sticks are always better” — they’re not — but “do we actually need an IV right now, or can capillary collection get us through this first set of labs?” When the answer is yes, the heel stick spares the infant from an invasive procedure that may have been unnecessary.

Beyond neonates, appropriate indications for capillary collection include patients with severely compromised venous access due to obesity, chemotherapy-damaged veins, burns, or scarring; patients for whom multiple venipuncture attempts would be more traumatic than a fingerstick; and POC testing scenarios where capillary collection has been validated for the specific analyte and device in use.

The Errors That Make Everything Worse

Capillary collection has inherent method differences from venous collection — but poor technique amplifies those differences significantly. The errors that cause the most trouble:

Milking. Squeezing or “milking” the puncture site to force blood flow is probably the single most damaging technique error in capillary collection. It introduces tissue fluid, causes mechanical hemolysis, and elevates potassium, glucose, and other analytes. If you are doing anything beyond a gentle squeeze to get adequate blood volume, then perhaps the puncture was inadequate — try a deeper lancet (not more than 2mm), a better-placed stick, or on a warmed site.

Skipping the warm. Warming the collection site for 3–5 minutes increases blood flow up to sevenfold and produces a much more arterialized specimen. Cold fingertips and cold heels produce sluggish, poorly arterialized blood that requires milking to collect and yields results that look more like venous blood than they should.

Not wiping the first drop. The first drop of blood contains tissue fluid, residual alcohol from skin prep, and cellular debris from the puncture itself. It must be wiped away. This is non-negotiable and yet it gets skipped regularly, especially when volume is tight and every drop feels precious.

Slow fill and clotting. Microcollection tubes need to fill promptly and be mixed as they fill. A slow fill from a cold or inadequately punctured site allows partial clotting to begin, which affects CBC results and coagulation testing. Remember the order of draw for microtainer tubes is EDTA, other additives, and then serum or no additive tubes last.

Document the Method. Every Time.

This is the part of capillary collection that has the least glamour and the most practical importance: if you collect capillary blood, document it.

The ordering provider may not know the specimen source unless you tell them. Reference ranges for some analytes are method-dependent. Clinical decisions — including medication adjustments, transfusion thresholds, and phototherapy initiation — can hinge on whether a result came from a heel stick or a venipuncture. If the method isn’t documented, a clinician comparing a capillary result to a previous venous result may conclude there’s an unexplained discrepancy when there isn’t one.

It’s a five-second notation that can prevent a cascade of unnecessary follow-up.

Back to the Beginning

The nurse who forgot about the heel stick wasn’t negligent. She was busy, she was trained to place IVs, and placing an IV is what she defaulted to when the order came in. What she needed — what a lot of bedside nurses and even some phlebotomists need — is someone with enough capillary collection knowledge to say: we have another option here, and here’s why it might be better.

That’s not a small thing. In neonates especially, every unnecessary procedure carries weight. Every undisturbed vein is a resource conserved. And every phlebotomist who understands not just how to do a heel stick, but when it’s appropriate and what its results actually mean, is adding something to that patient’s care that no one else in the room may be equipped to offer.

Same patient. Different numbers. Know why.

Looking for in-house training? We offer custom presentations with P.A.C.E. CE credit available. Whether you need help bringing attention to a troublesome topic that your department has had struggled with, or you want a fresh voice to cover the fundamentals, we are available! We will build topics around your needs. Presentations can be done in person or through a virtual meeting. Reach out to us for more details if you are interested :)

Subscribe now

Share

Leave a comment

The study, authored by Dolin and colleagues, took a real-world look at what happens when you introduce the Kurin Lock — a small, passive blood diversion device — across three distinct hospital units: an Emergency Department (ED), a Cardiothoracic ICU (CTICU), and a Medical ICU (MICU). Over six months before and six months after implementation, they tracked blood culture contamination rates and asked a straightforward question: does this thing work in the messy, variable reality of everyday patient care?

The short answer is yes — with some important nuances.

Overall, contamination dropped by 35.3% after the Kurin Lock was introduced. The ED saw a 41% reduction and hit below the 1% contamination benchmark during multiple months. The MICU told an even more compelling story: when researchers looked specifically at cultures drawn with the device, contamination came in at just 0.39% — compared to 3.02% in draws done without it. The device was estimated to have avoided approximately $170,378 (which would be $340,000+ annually) in contamination-related costs, using a cost-per-contamination figure of $6,553 from a prior meta-analysis.

But here is where it gets interesting, and where the post-publication conversation will likely focus: compliance varied dramatically by ward. The ED used the device 62.5% of the time. The CTICU just 32.2%. The MICU 35.4%. The CTICU, notably, never achieved the <1% benchmark and showed no statistically significant contamination reduction overall. The authors are transparent about this: the device works, but only when staff actually use it.

That is not a device problem. That is a training and culture problem — and it’s one phlebotomy educators and laboratory leaders need to understand in order to keep contamination rates low.

I’ve Been a Fan for a Long Time

If you perform blood culture collection, you understand how carefully the procedure has to be performed. From the extra thorough skin antisepsis, to cleansing the tops of the culture bottles, to being careful not to even breathe on the site you just scrubbed to avoid contamination — you understand the weight of this issue. Blood culture contamination isn’t just a quality metric on a dashboard. It means a patient may spend extra days in the hospital. It means antibiotics they don’t need. It means clinical staff chasing a ghost — a false-positive result that sends everyone down the wrong path.

At my hospital they implemented sterile gloves and surgical masks to try to prevent contamination. The gloves helped with people who tended to touch surfaces they weren’t supposed to, and the mask helped prevent mouth flora, which had shown up in false positives. These are helpful measures, but they don’t fix everything.

Initial specimen diversion devices solve a problem that even perfect technique can’t fully eliminate. Here’s why: no matter how meticulous your skin antisepsis, that first millimeter or two of blood after needle insertion carries a micro-plug of skin cells, surface bacteria, and debris from the puncture site. You can’t scrub that away. But you can divert it — physically route it away from the culture bottle before it has the chance to contaminate your specimen.

Despite nearly a decade of evidence and a growing body of research, ISDDs remain far from standard practice. Magnolia Medical — the pioneer in this space — counted adoption at nearly 500 U.S. hospitals in 2024. Out of roughly 6,100 facilities nationwide, that's a fraction. Most facilities drawing blood cultures today are still doing it the old way.

I believe every facility drawing blood cultures should be using an ISDD. The evidence supports it. The math supports it. And frankly, in a healthcare landscape where we obsess over quality metrics and patient safety initiatives, the question shouldn’t be whether to use a diversion device — it should be which one and how do we get compliance up.

First, Let’s Talk About SteriPath.

Many of you have probably heard of SteriPath, made by Magnolia Medical Technologies — now co-marketed in partnership with BD. It was the pioneer in this space, the original commercially available ISDD, and it has the deepest clinical evidence base of any device in this category. Twenty studies support its use, and across those studies it has consistently driven contamination rates to 1% or below.

The original SteriPath works by mechanically diverting and sequestering the first 1.5 to 2 mL of blood into a sealed chamber before allowing blood to flow into the culture bottles. It operates as a closed, vein-to-bottle sterile system and integrates with BD Vacutainer push-button blood collection sets. The Gen2 version, released in 2018, refined usability with a single-step activation design.

In 2020, Magnolia answered one of the most practical criticisms of the standard SteriPath — that 1.5 to 2 mL is a significant blood volume to divert in patients who can’t afford to lose it — by launching the SteriPath Micro. Designed in close collaboration with leading pediatric and adult hospitals, the Micro diverts less than 1 mL of blood and is specifically engineered for patients with low blood volume or difficult venous access. Think your tiny veins in the NICU, your oncology patients, your elderly patients with fragile, rolling vessels. For those populations, losing nearly 2 mL to a diversion chamber on every blood culture draw isn’t trivial — and the Micro addresses that directly. An expanded family of 19 Micro configurations received additional FDA 510(k) clearance in 2023, giving facilities a wide array of needle and collection configurations to match their protocols. Click here to see a video about the SteriPath Micro.

Both SteriPath and SteriPath Micro still require the user to physically activate the diversion — there’s a button involved. When used correctly, this is a minor step. But in the real world of busy EDs and ICUs, along with staff who may not understand the purpose of the blood diversion, any extra action in a workflow is an opportunity for someone to skip it. That’s not a knock on the device; it’s just an honest observation about human behavior in high-pressure clinical environments.

So How Does the Kurin Lock Compare?

The Kurin Lock, made by Kurin Inc. out of San Diego, takes a fundamentally different mechanical approach. Rather than actively diverting blood through user activation, the Kurin passively sidelines only the first 0.15 mL into a small flash chamber — no button, no squeeze, no activation step. The collector draws blood exactly as they always would, and the device handles diversion automatically.

Kurin has since expanded its line as well. The Kurin Jet, launched in 2023, is a newer ventless passive device that builds on the same no-activation concept. The original Kurin Lock is now called the Kurin Flash within the product family. In less than a decade, this space has gone from a single pioneering device to a full competitive market — a sign of both clinical urgency and growing demand. Click here to see all the info about this device, including a video.

When it comes to effectiveness, both devices work. The best head-to-head comparison data available found device-specific contamination rates of 0.68% for Kurin and 0.8% for SteriPath when the devices were actually used — essentially equivalent outcomes. Where the real-world gap shows up is compliance, and that gap is significant. In user experience surveys from that head-to-head study, SteriPath was rated worse than the standard of care by 73% of users compared to just 30% for Kurin, with the activation requirement being the primary sticking point. People preferred not having to push a button.

The Bottom Line.

The Dolin et al. study is valuable not because it reveals something we didn’t know, but because it confirms it in a messy, real-world multi-ward setting where compliance is imperfect and conditions aren’t controlled. ISDDs work. They work even when they’re used inconsistently. Imagine what happens when you get compliance up.

The CLSI has set a target of less than 1% for blood culture contamination. The CDC echoes that benchmark. Facility after facility using these devices — regardless of which brand — is hitting that number. Some are getting below it. One health system reported dropping from 2.85% to under 1% after switching devices, with estimated additional annual savings of $4.9 million from that change alone.

Under 3% was once considered acceptable. Under 1% is now the goal. And based on the evidence, it’s not just achievable — it’s expected.

If your facility is still drawing blood cultures without a diversion device, this study is your nudge. The device works. The data is there. The question now is whether leadership is ready to prioritize it — and whether your phlebotomy and nursing teams are trained and empowered to use it consistently.

Because as the Dolin study makes clear: the device is only as good as the hands that use it.

Subscribe now

Share

Leave a comment

Got questions about blood collection? The Lab Draw Answer Book answers over 400 of them — culled from years of real questions asked by nurses, phlebotomists, and educators, and fully referenced against current CLSI standards. It's the desk reference you'll actually reach for. Grab your copy at phlebotomy.com.

Before we get into this week’s Shift Notes, I have an announcement!

If you’re in the Virginia Beach area — or close enough to make the drive — I’d love to see you at the ASCP Virginia Chapter Phlebotomy Seminar on Tuesday, June 23rd at the Advanced Technology Center in Virginia Beach. The event runs from 7:30 AM to noon, and registration is just $30 for ASCP members and $35 for non-members. Students get in free with a valid college ID.

I’ll be presenting on preanalytical considerations and specimen integrity, along with pediatric blood collection techniques. Joining me is Lisa Ballou, MS, MLS(ASCP)DLM, Laboratory Director at Riverside Doctors’ Hospital in Williamsburg. Lisa brings over 35 years of experience in laboratory medicine — including performing and managing phlebotomy teams across outpatient, inpatient, psychiatric, and forensic settings — and she’ll be covering patient satisfaction and communication skills in phlebotomy. It’s going to be a great morning with some topics that don’t always get the attention they deserve.

The venue is at 1800 College Crescent, Virginia Beach, VA 23453. Use this link to register today.

Hope to see some of my readers there!

Okay, back to our topic for today…

I’ve mentioned before that I frequently lurk in the r/phlebotomy community on Reddit. It’s a good place to hear about the experiences of phlebotomists and see what’s going on in the phleb world. Unfortunately, one common theme I tend to see is… bullying.

Recently, someone posted about an experience of being bullied. She was new to the medical world, and a new phlebotomist. She acknowledged making some mistakes, though not many — which of course is perfectly normal for anyone, especially a new hire. Her trainers and some of the more experienced staff had told her she was doing well and learning fast. But another group on the floor was cold and dismissive — whispering, laughing, going quiet when she walked in. She knew what was happening and understandably, it was hard for her to shake off.

One commenter had a similar story. She was a new grad who had landed a job at a major national laboratory, a job she was excited about. Her trainer had no patience for her from the start. Every day brought a fresh round of complaints about how bad she was, how she wasn’t trying hard enough. A coworker would complain about her loudly enough that she could hear every word. After two months of this daily treatment, being told she was weak-minded, and even crying during her shift, she quit. She knew finding another phlebotomy job would be hard. She left anyway.

Another commenter shared how she did everything right — showed up early, filled her downtime by emptying trash and restocking supplies, and made no errors in her first few draws. Her coworkers talked about her and laughed while she was nearby anyway.

These are anonymous accounts from an internet forum, but anyone who has spent time in phlebotomy — or really, in any healthcare setting — knows these are not rare stories. They are common enough that a post called “Dealing with Mean Girls” gets a decent amount of interaction from people sharing similar experiences and trying to give helpful advice.

When this is going on, your new hire probably isn’t going to tell you about it. Instead they’ll just stop showing up.

I Know What This Feels Like

When I started working at the hospital, there were three older, well-seasoned women who made my work life genuinely miserable. They were friends, they sat together, and they gossiped about everyone — including me. They weren’t just cold. They were cruel. It got bad enough that even though I loved my job, I thought about quitting just so I wouldn’t have to deal with them.

I also thought about going to my manager or HR, but there was nothing substantial I could take to them besides telling them that these women went out of their way to say mean things, acted like I wasn’t doing my job, and refused to teach me. If I made a mistake, it was an opportunity to shame me publicly. One of them was close friends with the manager, and I didn’t believe anyone would listen to me over women who had been there for twenty years. So I kept working and did my best to avoid them. I eventually switched to nights to get away from them entirely, and I was much happier there.

Bullying isn’t theoretical, and it isn’t limited to young or inexperienced workers with something left to learn. Sometimes that’s the profile. But sometimes the person making a new employee’s life miserable has been in the profession for twenty years and simply never decided to be better.

How It Happens — and Why It Spreads

Phlebotomy programs can be completed in a matter of months, which means some people enter the workforce very young, without much experience navigating a professional environment. They haven’t had many opportunities to learn what professional conduct actually looks like — how to separate personal feelings from professional responsibility, how to be a colleague rather than a rival. How to have a professional disagreement rather than an argument or fight. That’s not necessarily a character flaw. It’s a gap. But it creates the right conditions for a clique mentality to take hold.

It only takes one person. Once someone establishes that gossiping is entertainment and excluding the new person is acceptable, others follow — not always because they’re cruel, but because social dynamics are powerful and it’s easier to be in the group than outside of it. By the time you notice, you’re not dealing with one difficult employee. You’re dealing with a culture. A toxic group of employees that are poisoning the workplace.

But age and inexperience don’t explain all of it — not even close. This behavior exists across every age group and credential level. Sometimes it’s immaturity. Sometimes it’s resentment from people who came up in difficult environments and have decided everyone else should too. And sometimes it’s just who a person is.

Bullying on a phlebotomy floor also rarely looks dramatic. There’s usually no screaming, no documented incident — just an eye roll when a new person asks a question, a complaint made just loudly enough to be overheard, withholding help when a draw goes sideways, whispering that stops when someone walks in. None of it shows up easily in documentation. All of it communicates the same thing: You don’t belong here.

The profession’s pace and culture make this worse. High-volume environments stretch experienced staff thin. Onboarding is often inadequate, leaving new hires dependent on whoever happens to be working that day — and that dependency is exploitable. And because phlebotomy supervisors are typically promoted for technical skill rather than people management, interpersonal dynamics that would be obvious to a trained manager can be genuinely invisible to a well-meaning one.

What It Costs You

Before we get to solutions, consider what you’re actually paying when this goes unaddressed.

You lose people — not the ones who can’t do the job, but the ones with enough self-respect to leave.

The new grad who cried through her shifts at that lab was talented enough to get hired right out of school. She’s gone now, and the profession is poorer for it. Beyond the human cost, a new phlebotomist who is demoralized and afraid to ask questions makes more pre-analytical errors. Your department also develops a reputation — HR hears things, nursing staff hears things, other departments talk. Negative Glassdoor reviews shy away good applicants. A floor known for eating its new hires will eventually struggle to recruit anyone worth keeping.

They either quit, or they conform and add to the toxic culture. A rare few endure. They stay and try to change the culture when they have the opportunity. Those people are worth their weight in gold.

The numbers back this up. The Workplace Bullying Institute estimates that 27% of American workers have experienced workplace bullying, with another 21% having witnessed it. In healthcare specifically, research puts that number closer to 28% annually — and those are only the cases people report. Studies consistently show bullying is underreported, particularly when victims fear retaliation or assume nothing will be done. One Pennsylvania Patient Safety Authority analysis noted that events may not even be recognized as reportable “if bullying is viewed as normalized behavior.”

That last phrase is worth sitting with. It used to be normalized. It was accepted as part of the job, part of paying your dues. What has changed is that organizations — the Joint Commission, the AMA, the ANA — have spent the last decade or so formally naming it as unacceptable and tying it directly to patient safety outcomes. The behavior hasn’t disappeared. The tolerance for it is supposed to have. Whether it actually has on your floor is something only you can answer.

This Is Your Problem to Solve

If this is happening on your floor or in your department — whether you created it, inherited it, or didn’t know about it, then it needs to be fixed. The culture that may be happening on one floor is the culture of the whole department. If you’ve seen something that looked like this and moved on without addressing it, you’ve communicated that it’s acceptable. Bystander inaction is endorsement, even when it’s unintentional.

When you address it, expect pushback. She’s just too sensitive. He can’t take a joke. They need to toughen up. Hold the line. The standard you’re enforcing is not whether someone can take a joke — it’s whether your department treats people with professional respect. Those are not the same conversation, and you don’t let them become one.

When you sit down with the employee whose behavior needs to change, be specific. Not you have a bad attitude — that’s too easy to argue with. Instead: I’ve observed that when [name] asks questions, you respond in a way that shuts the conversation down. That changes today, and here’s what I expect instead. Specific. Observable. Non-negotiable.

If the behavior involves a group dynamic, address it as one. That may mean separate conversations, structural changes to who works alongside whom, or both. Make clear that the culture you are building does not have room for what they’ve been doing.

Building a Department That Doesn’t Eat Its Young

Addressing what’s wrong is only half of it. The other half is being intentional about what you build instead.

Assign preceptors/trainers by temperament, not seniority. The most experienced person in the department is not automatically the right person to train someone new. Look for the tech who enjoys teaching, who has patience in their bones, who remembers what it felt like to not know something. That’s your preceptor.

Set explicit behavioral expectations. Patience with new staff is not a personality trait you hope your employees have. It’s a professional expectation you communicate clearly — in orientation, in staff meetings, by name.

Address it before it starts. Don’t wait for a problem to surface before setting the expectation. Professionalism with coworkers — what it looks like, what it doesn’t — should be part of your regular staff training throughout the year. Not as a response to an incident, but as a standing rule. When your team hears it consistently, it stops being a warning and becomes the culture.

Create a simple check-in structure. At 30, 60, and 90 days, ask your new hires directly: How are things going? Are there relationships on this team that feel difficult? Do you feel like you can ask for help? You won’t always get honest answers. But asking signals that you’re a supervisor who wants to know, and that signal matters more than you might think. Anonymous surveys can also be very eye-opening (and sometimes brutal), but they let us see real feedback without fear of retaliation.

Recognize the people who do it right. You have staff who are warm, patient, and genuinely good to new people. Tell them — publicly — that you notice and that it matters. Culture is shaped by what gets rewarded, not just by what gets corrected.

The Standard You Set

A phlebotomy department has two jobs. The first is the clinical work — accurate, safe, patient-centered collection. The second, which gets far less attention, is the ongoing work of being a team — maintaining an environment where people can do that clinical work without being torn down by the people standing next to them.

You set the standard for both. Not by what you say you expect. By what you allow.

The new grad who cried through her shifts and eventually quit — her trainer had a supervisor. Her supervisor had the ability to intervene. Whether that supervisor knew what was happening, we don’t know. Whether they did anything about it… the outcome tells us no.

Your new hire is watching to see what kind place they’ve landed in. Make sure they see something worth staying for.

Our new Shift Notes series will be published about every two months. Have a topic you’d like to see covered? Let us know in the comments, or reach out to us!

Subscribe now

Share

Leave a comment

And it is not a rare problem. According to CLSI standards, 160,000 adverse patient events occur in the United States every year because of patient or specimen ID errors involving the laboratory. Up to 1% of collection tubes are mislabeled. Eleven percent of all transfusion deaths are linked to a failure to properly identify the patient or correctly label the tube. And up to 7.4% of patient ID bands are missing or contain erroneous information — meaning nearly one in thirteen wristbands you check may be wrong before you’ve even started.

I know most phlebotomists genuinely care about doing this right. But caring and doing are two different things, and the cases I want to share with you today didn’t happen because someone didn’t care. They happened because of shortcuts that probably felt harmless in the moment. They happened because of a busy morning, a shift change, and the quiet assumption that someone else would catch it.

Nobody did.

Case Study #1: Right Patient, Wrong Sample

This case was published by AHRQ’s Patient Safety Network and has been used in medical education for nearly two decades. I’m drawing on it here because it is one of the cleanest illustrations I’ve ever seen of how a single procedural shortcut can set an entire chain of events into motion.

A 54-year-old man was admitted to the hospital for a preoperative workup ahead of elective knee surgery. The morning of his procedure, a phlebotomist came in to collect blood for his basic labs and, critically, his type and crossmatch — the specimen the blood bank uses to identify his blood type and match compatible units in case he needs a transfusion during surgery.

The hospital had a policy in place for exactly this kind of draw. Before any specimen intended for transfusion purposes could leave the floor, a registered nurse or physician was required to verify the patient’s identity and initial the label on the vial. It was a second check. A safeguard. The kind of redundancy that exists precisely because the stakes are high.

But it was the change of nursing shift. The patient’s bedside nurse wasn’t available. No physicians were on the floor. And the phlebotomist still had another entire floor of patients to see.

So she carried the labeled tubes out to the nurses’ station and had a random nurse — someone who had not seen the patient, had not verified his identity, and had no idea whose blood was in those vials — sign off on the labels. Then she sent the tubes to the lab.

The problem surfaced hours later, not because anyone at the bedside caught it, but because a lab technician noticed something strange. The hemoglobin result for a different patient on the same floor looked dramatically different from that patient’s value from the day before. That kind of delta — a sudden, unexplained shift in a result — is the kind of thing that makes a good lab tech stop and ask questions.

She dug into it. What she found was that all of the 54-year-old man’s tubes had been mislabeled with another patient’s label. The hemoglobin anomaly existed because the lab was looking at the wrong man’s blood and crediting it to the right man’s chart. And the type and crossmatch vial — the one that would have been used to match blood for his surgery — was also wrong.

The patient was redrawn in time. He went into surgery safely. No transfusion with mismatched blood occurred. But the only reason this ended without harm is that one lab technician’s instinct to follow up on a strange number. There was no system-level catch. No alarm. No second check that worked the way it was supposed to. Just one person deciding not to let a weird result slide.

That is a paper-thin margin.

Case Study #2: Four Failures in Four Weeks

The second case is actually a cluster of cases — four separate patient misidentification events reported to a large hospital’s patient safety committee within a single four-week window. This one was also published by AHRQ’s Patient Safety Network, and it’s the kind of report that’s uncomfortable to read because it doesn’t read like a story about careless people. It reads like a story about a system under pressure.

The event most relevant to our world involves two young men who arrived at the emergency department at overlapping times. One was 23, found unconscious outside a bar with facial injuries and bruising on his chest and abdomen. The other was 21, with facial injuries following a motor vehicle accident. Similar ages. Similar presentations. Neighboring rooms.

CT scans were ordered for both. When the results came back, they were charted under the wrong patients’ names — each man’s results appearing in the other’s chart. To make it worse, a CT of the abdomen and pelvis had been ordered only for the first patient, but it was performed on the second. A scan that wasn’t ordered for him, wasn’t needed for him, and exposed him to radiation without any clinical indication.

The error was eventually caught because the clinical team noticed the results didn’t match what they were seeing on physical exam. The imaging was re-done correctly and the records were fixed. But consider for a moment how different that outcome could have been. If the first patient’s abdomen scan had been missed because it appeared done — and he had internal bleeding — we would be talking about a very different case.

The other events in the same four-week period included a 68-year-old woman who received a contrast CT of the wrong body part because she shared a first name with another patient, and a 2-year-old girl who came out of surgery wearing an 8-month-old boy’s ID band. Four separate events. Four separate failures. One month.

The researchers who analyzed these cases identified the same root causes over and over: similar names, physical proximity of patients, high caseload, and failure to follow ID verification protocols at the point of care. These are not exotic problems. These are any old regular Tuesday.

What CLSI Standards Actually Require — And Why Every Detail Matters

CLSI standards for patient identification are not vague on this. The requirements are specific, and they are specific for a reason. A new version of this standard, CLSI PRE01 — Patient and Laboratory Specimen Identification Processes — is now available and continues to codify these requirements.)

Two unique identifiers are required before every draw. The standard combination is full name and date of birth — chosen specifically because patients can state them from memory, which is the whole point of the verbal confirmation. Not room number. Not bed tag. Those are not identifiers — they’re locations, and locations change. Patients get transferred. Charts get moved. A wristband hanging on a bedrail belongs to whoever is assigned that bed today, and today’s patient might not be the same as yesterday’s.

The patient must verbally state their information, and the phrasing matters more than most people realize. CLSI standards are explicit: you must ask open-ended questions that elicit specific information and cannot be answered with a simple yes or no. Ask the patient to state and spell their full name. Ask for their date of birth. You do not say “Are you John Smith?” and accept a nod. You do not read the name off the requisition and watch for confirmation. You do not show the patient the order and ask if it’s correct. A nod is not identification. A grunt is not identification. A patient who is confused, half-asleep, or simply agreeable will nod at almost anything — which means you have confirmed nothing.

For inpatients, the wristband is a parallel check — not a substitute for the verbal confirmation. You still ask the patient to state and spell their name and give their date of birth. Then you cross-reference what they said against the wristband, which carries both the patient’s name and their patient-specific identifier (medical record number). All three must match: what the patient says, what’s on the band, and what’s on the order. And that wristband must be on the patient’s body. Not scanned from across the room. Not read off a bed rail or nearby table. CLSI standards are explicit that you must not rely on a bed tag, ID bands not attached to the patient, or charts or records placed on the bed, nearby tables, or equipment. If the wristband is missing, that is a stop point. You do not proceed until identification is established through proper channels.

For outpatients without a wristband, you ask the patient — or their guardian or caregiver if the patient cannot respond — to provide, not affirm, the same information. The standard is clear on this distinction: a family member or caregiver confirming a patient’s identity must provide the information independently, not simply agree with what you’ve already said. And for conscious patients who have a communication barrier, written identification is required.

When the draw is complete, only then do you apply the labels to the samples. Not before, and it needs to be at the bedside of the patient within their sight. Then you can ask them to once again verify that the labels now attached to the blood tubes are correct, and you can leave that patient with complete confidence that proper procedure was followed and the labeled samples belong to the correct patient.

And if there is any discrepancy between what the patient tells you and what appears on the order — however minor — you stop. You do not resolve it yourself. You do not make an assumption and proceed. You stop and you get it sorted out before a needle goes anywhere near that arm.

Look back at Case Study #1. The phlebotomist had already labeled the tubes. She knew there was a second-check policy. She chose to work around it because she was busy and the right person wasn’t available. And beyond the policy violation, she violated CLSI’s requirement that specimen containers be labeled immediately after collection, in the patient’s presence, by the health care professional who collected the specimen. Carrying tubes to a nurses’ station to get a random signature is the opposite of that. It was a shortcut layered on a shortcut.

It wasn’t fine.

The Bigger Picture

These two cases are educational near-misses. Nobody died (this time). But the consequences of a completed patient ID failure can be catastrophic and they have been. A mismatched type and crossmatch specimen can result in a patient receiving incompatible blood during surgery. ABO-incompatible transfusions trigger an acute hemolytic reaction — the immune system attacks the transfused red blood cells, releasing a cascade of toxic substances that can cause shock, kidney failure, and death. According to CLSI standards, 11% of all transfusion deaths are attributable to a failure to properly identify the patient or correctly label the tube. It is one of the most devastating outcomes in transfusion medicine, and it begins with a label.

The Joint Commission has identified patient misidentification as a leading cause of sentinel events — unexpected occurrences involving death or serious harm. Between 2014 and 2017 alone, 409 of the 3,326 sentinel events reviewed involved patient identification failures. Root cause analyses at Veterans Health Administration hospitals found that 72% of errors in the laboratory test cycle were traceable to patient misidentification. And those numbers reflect only what was reported and caught. CLSI standards note that 15% of patient identification errors go undiscovered entirely.

The Question That Changes Everything

I want to close with something I come back to every time I teach patient ID. When you walk into that room and you approach that patient, you are standing at the only point in the entire laboratory testing process where someone can look a human being in the face and ask questions. The lab can’t do it. The pathologist can’t do it. The physician reviewing results can’t do it. You are it.

That question — “Can you please state and spell your full name and tell me your date of birth?” — is not a formality. It is the entire defense. It is the moment where a mislabeled requisition gets caught, where a transferred patient gets identified correctly, where a confused elderly person gets a second look before a needle is placed. Every case I’ve described in this post had a moment — usually more than one — where that question, asked properly, would have stopped the chain.

Ask it every time. Ask it out loud. Ask it in a way that requires an answer, not a nod. And if something doesn’t match, stop.

The phlebotomist in Case Study #1 was probably a decent phlebotomist on any other morning. She was busy, she was running behind, and she made a judgment call that felt reasonable in the moment. I don’t think she was reckless. I think she was human. But that’s exactly why the standard exists — not for the easy days, but for the busy ones.

Looking for documents to use in your phlebotomy program? We’ve got you covered with our Phlebotomy School Start-up resources. One of our popular documents is a customizable practice requisition sheet that contains 127 different blood tests. Students can use different lab test menus to look up the requirements for the tests you select, and practice assembling tubes and drawing those tests according to the requirements. Plus it comes with a color-coded cheat sheet for you, and a list of databases students can use. Only $19.99!

Subscribe now

Share

Leave a comment

_Sources:

_{Astion ML. Right Patient, Wrong Sample. PSNet. Agency for Healthcare Research and Quality; 2006. https://psnet.ahrq.gov/web-mm/right-patient-wrong-sample}

_{Choudhury LS, Vu CT. Patient Identification Errors: A Systems Challenge. PSNet. Agency for Healthcare Research and Quality; 2020. https://psnet.ahrq.gov/web-mm/patient-identification-errors-systems-challenge}

_{Barnhard S. “This is the wrong patient’s blood!”: Evaluating a Near-Miss Wrong Transfusion Event. PSNet. Agency for Healthcare Research and Quality; 2020. https://psnet.ahrq.gov/web-mm/wrong-patients-blood-evaluating-near-miss-wrong-transfusion-event}

_{CLSI. Accuracy in Patient and Specimen Identification. 2nd ed. CLSI standard GP33. Wayne, PA: Clinical and Laboratory Standards Institute; 2019. [Statistics on transfusion deaths, adverse events, mislabeling rates, and ID band errors cited from Section 1.2, Background, p. 2. Patient identification protocol requirements cited from Chapter 3.] Note: A new version of this standard, CLSI PRE01 — Patient and Laboratory Specimen Identification Processes — is now available.}

_{World Health Organization. Patient Safety Fact Sheet. September 2023. [Joint Commission sentinel event data cited.] https://www.who.int/news-room/fact-sheets/detail/patient-safety}

When I was a very young instructor in my early twenties, I would sometimes get a type of student who, at the time, stressed me out a lot. This student would often be older than me, and they would ask me hard questions that differed from what I was teaching in the classroom. One of these students was a woman who had previously worked as a phlebotomist, but hadn’t worked in many years after getting married and having a few children. With her kids getting older, she had decided to return to the workforce and was taking the class to get a refresher on phlebotomy knowledge and a shiny new certificate.

I am sure she saw me — a young teacher with only a few years of both phlebotomy and teaching experience — and immediately questioned if she was getting her money’s worth. I don’t blame her at all for thinking that way. She was twice my age and had more phlebotomy experience than me. As I’ve gotten older, I have taken classes where I felt much the same, watching some young new instructor and questioning their knowledge.

The problem was that her previous experience was outdated, and most of it was incorrect. She had a lot of questions, and had a hard time accepting the new information from me, a young educator still trying to find her teaching style. She would ask challenging questions in front of the class — things that differed from what I had just explained. She would argue that certain things were unrealistic, or that this was not how she had seen it in the real world.

She had learned to stick at a 45-degree angle with her straight needles, ripped the fingertip of her glove off before drawing, always marked the vein with a pen (something I didn’t allow), learned an order of draw that started with red tops first, and brought a handful of other habits that all needed to be corrected.

Every day was a new topic that she had questions or disagreements about. I dreaded having to deal with her, and made sure I was as prepared as possible with my information to counter her arguments. She didn’t yell, she wasn’t really rude (but also not very nice), and she pushed. She wanted to know why things were different, why it was better, when it had changed. Most of the things she asked were perfectly reasonable, but some of them became arguments just because she didn’t like the changes.

The imposter syndrome was strong. I felt like she was undermining my authority in front of the whole class every time she asked her questions. I had never had a student challenge me so much. There were other problematic students in that class too (for different reasons), and every day I felt like I was running the gauntlet. It was the first class (but not the last) that made me question if I was cut out to be a teacher.

She taught me so much.

My first instinct was to be defensive and give her answers that essentially said “this is the way it is.” But I knew that wouldn’t work. I hated answers that weren’t real answers, and I had always struggled myself when teachers or parents or whoever said that to me. I want to know more. Don’t dismiss me, tell me why. So, for this particular student and for all my challenging students like this in the future, I explained. I taught. Sometimes I said “I don’t know.” And over time, her questions became less pushy, less challenging towards me. She still asked plenty of them, but she was gentler, a little more respectful.

At the end of the program, she told me she thought I was a good teacher, and that she had learned a lot. She had been nervous to return to school after so many years, and she was the oldest person in the classroom by far. She didn’t know if she could do this anymore, but she had learned that she could. After breaking her bad habits, she had done well, and she had aced every test. She felt confident to re-enter the workforce. She thanked me — and my cortisol levels finally dropped back to normal.

Instructors who teach in phlebotomy programs and courses are hired based on clinical experience. We aren’t formally trained educators who have been taught how to handle a classroom with difficult students and complicated situations. We are often learning how to be a teacher just as much as the students are learning how to be healthcare professionals. They feel like they have to have all the answers and be the absolute authority on the subjects they are teaching — and honestly, so did I.

When a student pushes back on your instruction — especially in front of the class — it’s easy to take it as a personal challenge. But the way you respond will define your classroom far more than the challenge itself.

The experience of that student stayed with me. Not because she was my worst (she was nowhere near the worst), but because she was a real test as an instructor. And if you’ve spent any time teaching in any capacity — whether in a formal program, a hospital orientation, or a one-on-one training session — you’ve probably met a version of her too.

The student who argues.

Not the one who asks thoughtful questions. Not just because they need extra clarification. The one who pushes back. Repeatedly. Sometimes in front of everyone.

Here’s what I’ve learned after years of teaching: how you handle that student says more about your classroom culture than almost anything else you do.

It’s Not About You

The first thing to get right is this — pushback from a student is almost never a personal attack, even when it feels like one.

When a student challenges your instruction, they’re usually not trying to undermine you. They’re drawing on their own experience, something they read, something a previous instructor told them, or simply a confidence in their own knowledge that outpaces their actual skill level. That’s a teaching problem, not a threat to your authority.

The moment you take it personally, you’ve already lost the upper hand — not because the student won, but because you’ve shifted from educator to defender. Nobody learns anything when the instructor is busy protecting their ego.

That’s easier said than done, especially early in your teaching career. When someone challenges what you just taught in front of a room full of students, the instinct to prove yourself is real. Resist it. Take a breath. Then teach.

“That’s a great question, and a pretty common misconception. Here’s why…”

You Don’t Have to Know Everything

Here’s something I wish someone had told me when I first started teaching: you are allowed to not have every answer.

If a student raises a point that genuinely gives you pause — something you’re not sure about, something that’s evolved in the literature, something worth looking into — say so. “That’s a great point. I want to make sure I give you an accurate answer, so let me follow up on that.” Then actually follow up.

What you can’t do is make something up, dismiss the concern entirely, or get flustered. Students respect honesty, and they can sniff out lies like a bloodhound. What erodes your authority isn’t admitting uncertainty — it’s being caught in an error you insisted wasn’t one.

That said, there’s a difference between genuine uncertainty and a student trying to convince you that the wrong way is acceptable. When a student argues against established standards — CLSI guidelines, best practice protocols, institutional policy — that’s not a knowledge gap you need to fill. That’s a redirection moment.

Validate, Then Hold the Line

One of the most effective things I’ve ever done in a classroom is validate a student’s reality before redirecting them to the standard.

I had another student who had worked as a phlebotomist years before returning to formal training. A few times throughout the course, she would periodically announce, in front of the class, that in her previous workplace they allowed a two-minute tourniquet application time — and that the one-minute standard we were following seemed unrealistic. She wasn’t hostile about it. She wasn’t asking a question, either. She was stating it as fact, and other students were listening.

I could have dismissed her. I could have told her that what she did before didn’t matter here. Instead, I acknowledged her.

“You’re right that loose tourniquet time rules are pretty common in the field. A lot of facilities don’t enforce the one-minute limit strictly, and I understand that’s what you experienced. But common practice and best practice aren’t always the same thing. Here’s why the standard exists — and here’s what the evidence says happens when we exceed it.”

Then I covered tourniquet time again. For everyone.

She never argued that particular point again. And the rest of the class got a reinforcement of a critical concept they probably needed to hear twice anyway.

The formula is simple: acknowledge what’s true, clarify what’s standard, explain why it matters. You’re not agreeing with them. You’re not dismissing them. You’re teaching — which is exactly what you’re supposed to be doing.

When It Becomes a Pattern

A student who argues once is giving you a teaching moment. A student who argues every class is giving you a classroom management problem.

If a particular student is repeatedly challenging your instruction, disrupting the flow, or creating a dynamic where other students are unsure who to listen to, it’s time to address it directly — and privately.

Don’t do this in front of the class. Pull the student aside during a break or after class and have a straightforward conversation. Something like:

“I’ve noticed you’ve had some strong reactions to a few of the things we’ve covered. I want you to know that questions and discussion are always welcome — I encourage that. But I also want to make sure the classroom stays productive for everyone. If you have a concern about something I’ve taught, I’d love to hear it. Let’s talk about it here, and if there’s something worth addressing with the group, we’ll do that.”

This does several things. It shows the student you’re not afraid of them. It opens a real dialogue rather than a performance. It makes clear, without making a scene, that the current pattern isn’t working. And it often reveals something useful — sometimes the arguing student is covering for anxiety, a past bad experience, or a genuine misunderstanding that hasn’t been resolved.

Always document these conversations when they happen. If the behavior continues and you eventually need to escalate to a formal concern, you’ll want a record.

Keeping Your Authority Without Losing Your Cool

Authority in the classroom isn’t something you demand. It’s something you demonstrate — through your knowledge, your consistency, your composure, and the way you treat your students even when they make it difficult.

The instructor who snaps at a challenging student, shuts down questions, or visibly bristles at pushback loses the room. Not just with that student — with everyone watching.

A few things that help:

• Stay curious, not combative. When a student challenges you, get interested. Ask them to tell you more about where they learned that. Often the answer itself reveals the disconnect, and you can address it from a place of information rather than reaction.

• Keep your voice even. The tone you set when a student pushes back tells the class everything. Steady and calm communicates confidence. Elevated and defensive communicates insecurity — even if your content is correct.

• Redirect to the standards, not to yourself. When you need to hold a line, hold it against the guideline, not your own preference. “The CLSI standard and your textbook require this” lands differently than “this is how I teach it.” One is an authority the student can look up. The other is a personality conflict waiting to happen.

• Know when to table it. If a debate is going nowhere and eating up class time, it’s okay to say, “I think this is worth a deeper conversation — let’s plan to talk after class and we’ll get back to the group if there’s something worth sharing.” That’s not backing down. That’s running a classroom.

Stay professional, stay patient, stay kind, and when you educate your students with firm rules and correct information, they will listen.

The Student Who Argued — And What She Taught Me

Looking back on the student I described at the beginning of this post, I’m grateful for her. Not because she made my life easy — she didn’t. But because she made me a better instructor.

She forced me to know my material cold, to be prepared for challenge, and to learn the difference between confidence and defensiveness. She taught me that my job isn’t to be right in front of students — it’s to help them understand what’s right, and why.

The argumentative student is a fixture of every teaching career. When you learn to see them not as a threat to your authority but as an invitation to demonstrate it, they stop being your hardest students. They become some of your most useful ones.

Subscribe now

Share

Leave a comment

Looking for training materials? We’ve got you covered. Check out our bestselling educational videos. Perfect for both classroom and clinical training. Available for streaming or on DVD.

Let’s get into it.

What the Tourniquet Is Actually Doing

When you apply a tourniquet, you’re partially occluding venous outflow from the arm while arterial inflow continues. Blood pools in the vein below the tourniquet, pressure builds, and the vessel distends — making it visible, palpable, and accessible. That’s the goal, and in the first sixty seconds or so, it’s all the tourniquet is doing.

The problem starts quietly, in the tissue surrounding the vein. As venous pressure rises, plasma begins to be forced out of the capillary beds and into the surrounding interstitial tissue. The blood remaining in the vein becomes progressively more concentrated — not because anything new entered the vein, but because fluid left. Think of it like reducing a sauce on the stove: you’re not adding anything, you’re just driving off water. What remains is thicker and more concentrated than what you started with. It makes for a delicious soup. It does not make for accurate test results. This is hemoconcentration, and it’s the mechanism behind nearly every pre-analytical error the tourniquet causes.

What Happens Past Sixty Seconds

CLSI PRE02 is unambiguous: the tourniquet should not remain in place for longer than one minute. That guideline isn’t arbitrary. It reflects the point at which hemoconcentration begins producing clinically meaningful changes in specimen composition.

Here’s what the research shows happens when that one-minute window closes:

Total protein, cholesterol, and calcium all increase as plasma water shifts into surrounding tissue. Because these analytes are large or protein-bound, they concentrate faster than smaller freely diffusible molecules.

Hemolysis risk climbs steeply. One study found the odds ratio for hemolysis when tourniquet time exceeded one minute was 19.5 — nearly twenty times the baseline risk. Hemolyzed specimens mean repeat draws, patient inconvenience, and delayed results.

Potassium is particularly vulnerable through two compounding pathways. Hemoconcentration elevates the potassium already present in plasma as fluid shifts out of the vascular space. More dramatically, hemolysis — which is nearly twenty times more likely when the tourniquet exceeds one minute — causes red blood cells to rupture and release their intracellular potassium directly into the specimen. The potassium concentration inside a red blood cell runs around 105 mmol/L — roughly 25 times higher than the normal plasma value of about 4 mmol/L — so when cells start rupturing, even modest hemolysis sends a significant potassium load flooding into the specimen. The result can push a normal result into the range that triggers a cardiology consult — for a patient whose potassium is completely fine.

Other affected analytes include iron, bilirubin, AST, and various enzymes that are sensitive to cellular disruption or hemoconcentration.

The longer the tourniquet stays on, the worse these effects become — and importantly, they don’t reverse the moment you release it. Once hemoconcentration has occurred in the vein, the blood in your tubes reflects that altered state. CLSI recommends that if a tourniquet has been applied for longer than one minute during vein assessment, it should be released and the arm allowed to equilibrate for at least two minutes before reapplication.

In real-world practice, this guideline is widely ignored. One study measured average tourniquet application time before a training intervention and found the mean was 118 seconds — nearly two minutes. Every lab, every day, potassium values are being read by clinicians who don’t know the tourniquet was on for two minutes or more.

Types of Tourniquets

Not all tourniquets are created equal, and phlebotomists working across different settings will encounter several varieties.

The flat disposable strip is the current standard of care and the type CLSI recommends. These are single-use, latex-free, and designed to be discarded after each patient. They’re fast to apply, easy to release with one hand, and cheap enough that there’s no legitimate reason to reuse them. This is what should be on your cart.

The Tournistrip is a newer single-use option worth knowing about. Made by ASep Healthcare, it’s designed to look and operate like a conventional tourniquet but with a few practical advantages. It won’t roll the way a flat rubber strip can, it’s easy to tension and adjust without tying, and single-handed release is built into the design. It can also be repositioned on the same patient up to five times without compromising the single-use principle. I’ve tested it and it works well — if you’re looking for alternatives to your basic disposable strip, it’s worth a look.

The fabric or Velcro tourniquet is reusable by design — a woven band with a hook-and-loop closure. These are comfortable for patients and easy to adjust, and they were popular for years. They’re also a contamination problem. The fabric weave harbors bacteria in a way that smooth disposable strips don’t, and they’re difficult to adequately disinfect between patients. If you’re still seeing these in your facility, that’s worth a conversation with infection control.

The rubber tube tourniquet — a length of latex or rubber tubing tied in a slipknot — is the historical predecessor to the modern strip and still turns up in some settings. Same contamination concerns as any other type, with the added problem that latex tubing poses a risk to patients with latex allergies. These should be retired, we have better alternatives now.

The tab-and-slot tourniquet — the older style with punched holes along the band that hook onto a small plastic clasp — was a step toward standardization but shares the reusability problem of the fabric type. These are often reused over and over. If you recognize this one, it’s had a long run. Its time is up. It is worth noting that there are some of these that are made to be single use such as this one also made by Asep Healthcare.

The blood pressure cuff is in its own category and gets its own section below, because its appropriate use goes beyond simple vein distension.

The Contamination Problem

The case for single-use tourniquets isn’t just about convenience. It’s about patient safety, and the research is uncomfortable reading.

A study published in the Journal of Hospital Infection gave phlebotomists a fresh, sterile tourniquet at the start of each working day. By the end of that day — after a normal volume of draws across multiple patients — 25% of those tourniquets were contaminated with MRSA. Not after weeks of reuse. After one day.

A separate cross-sectional study of 200 tourniquets in a tertiary care hospital found MRSA contamination in 26% of collected tourniquets, with rates varying significantly by ward. A 2023 systematic review confirmed MRSA as the most commonly found organism, turning up on 12% of all tourniquets tested across the studies reviewed.

The mechanism isn’t mysterious. A tourniquet is pressed against patient skin, handled by the phlebotomist’s gloved and ungloved hands, set down on surfaces, and stuffed into pockets or supply pouches — often repeatedly, between patients who may include MRSA-positive individuals in non-isolated settings. Disinfecting a reusable tourniquet between every patient in a high-volume draw environment is theoretically possible but practically rare, and likely to be done inefficiently due to time constraints.

WHO guidelines on best practices in phlebotomy recommend single-use devices for blood collection. CLSI echoes this. The disposable strip is not a luxury. It is the standard.

The Multi-Tube Problem

Here’s a scenario every experienced phlebotomist has faced: the order is for twelve tubes. The patient has one usable vein. You know before you apply the tourniquet that you will not complete this draw in sixty seconds. A good, cooperative vein can yield a lot of tubes in a well-executed draw — but double digits is a significant ask. The math simply doesn’t work: by the time you’re applying tube seven or eight, you’re well past the one-minute mark, and you’re collecting hemoconcentrated blood whether you acknowledge it or not. The longer the tourniquet has been on, the more compromised every subsequent tube becomes.

High tube counts aren’t the only situation where the clock becomes a problem. Sometimes draws are simply slower than anticipated. A butterfly to the dorsal hand can fill tubes so slowly that even four tubes can’t be completed within the one-minute window. And when you do release the tourniquet around the minute mark, tubes that were filling steadily can slow to a trickle — leaving you with a decision to make about whether to wait, reapply, or call it and come back with a second stick. In those cases, the calculus is the same regardless of how many tubes are on the order: a second stick is safer and more accurate than leaving the tourniquet on and hoping for the best.

There are a few legitimate strategies for managing this situation.

Release and reapply. If you’ve been in the vein for close to a minute and have tubes remaining, release the tourniquet, keep the needle secure, and wait two minutes before reapplying. Fill what tubes you can while the tourniquet is off. Yes, this adds time. Yes, it requires the patient to hold still. It’s still better than the alternative, which is delivering a potassium of 6.2 to a clinician who doesn’t know why. In practice, this technique requires a butterfly needle taped securely in place — you’ll need both hands free to reapply the tourniquet. This also aligns with CLSI’s requirement that all needles be secured for the duration of every blood draw, either by holding them or taping them in place.

Consider a second stick. Sometimes the right answer is to complete what you can safely within the first minute, withdraw, allow equilibration, and perform a second venipuncture for the remaining tubes. This is a harder conversation to have with a patient who just got stuck once, but it is safer and more accurate than completing a twelve-tube draw on a tourniquet that’s been on for four minutes. Patient safety and result integrity are the standard, not convenience.

Use a blood pressure cuff. This is my favorite, and the most effective strategy for high-volume draws or patients with difficult access, and it’s supported by CLSI standards.

The Blood Pressure Cuff as Tourniquet

When a conventional tourniquet isn’t sufficient — or when the draw volume makes the one-minute rule impossible to respect — a blood pressure cuff is a legitimate and well-documented alternative.

The principle is the same as the standard tourniquet: partial venous occlusion to distend the vein. The advantage is precision. Rather than applying unknown compression with a rubber strip, you inflate the cuff to just below the patient’s diastolic blood pressure — typically around 70 or 80 mmHg for a normotensive patient — which is sufficient to impede venous outflow without occluding arterial inflow. Earlier versions of the CLSI standard recommended a flat 40 mmHg, but the standard was revised when it became clear that 40 mmHg was insufficient for hypertensive patients and potentially excessive for pediatric and geriatric patients. Inflating just below diastolic accounts for individual variation.

The practical advantages are real:

• The cuff can be inflated for one minute, fully deflated, and reinflated after a two-minute rest — allowing you to work through a high-tube-count draw in controlled, compliant intervals.

• It can be applied and then operated with one hand once positioned, which is a meaningful ergonomic benefit during complex draws.

• Many modern automated blood pressure machines include a dedicated tourniquet setting specifically for this purpose, removing the need to manually monitor pressure.

The caveat is that using a blood pressure cuff as a tourniquet requires the phlebotomist to know the patient’s diastolic blood pressure. That means taking a blood pressure reading before the draw, or confirming a recent reliable value from the chart. A phlebotomist who cannot take a blood pressure cannot safely use this technique — inflating blindly to a fixed number reintroduces the same one-size-fits-all problem the standard revision was designed to solve.

The Bottom Line

The tourniquet is the most casually handled tool in the phlebotomy setup, and it is often one that causes the most silent pre-analytical damage. One minute is not a suggestion. Single-use is not optional. And when the draw is too complex for sixty seconds, the answer is a deliberate strategy — not optimism about how fast you can fill tubes.

The patient whose potassium comes back falsely elevated will be chased down for a repeat. The patient whose specimen hemolyzes will be stuck again. The patient on the wrong ward who picks up MRSA from a tourniquet that’s been in someone’s tray for a week — that’s a different kind of problem entirely.

Use the right tourniquet. Use it once. Watch the clock.

What strategies does your facility use for high-tube-count draws? Have you incorporated blood pressure cuffs into your practice? Share in the comments.

Subscribe now

Share

Leave a comment

But that strip has a history that runs through ancient Roman amputations, medieval barbershops, Civil War surgery tents, and early 20th-century hospital wards. And the core idea behind it — the reason it works at all — was never formally discovered. No paper announced it. No inventor named it. Because it didn’t need to be discovered. It needed to be noticed.

Most of us learned it as children. Wrap a rubber band around a finger and watch it turn purple. Wear a tight hair tie against your wrist and see the veins on the back of your hand rise to the surface. Tie a piece of yarn around your arm on a dare and feel your fingers go numb. Every kid who has ever done any of these things has independently stumbled onto the same physiological principle that barber-surgeons were exploiting in medieval Europe: partial constriction of a limb traps venous blood and brings veins to the surface. It is one of the most intuitive observations in the history of medicine, which is probably why no one thought to write it down as a discovery. It was just something that was true — obvious once seen, impossible to unsee.

What changed over time wasn’t the understanding. It was the context in which that understanding was applied. The knowledge was codified gradually in clinical manuals as assumed practice, accumulating the way a lot of practical knowledge does: through hands dirty with the work, generation after generation. The specific device in your drawer did eventually earn a patent — but not until 1991. For everything that came before it, there was just the observation, and the ingenuity to put it to use.

It’s worth tracing that arc.

The Barber-Surgeon’s Discovery

If you want to find the true ancestor of the venipuncture tourniquet, you don’t start on a battlefield. You start in a barbershop.

From roughly the 5th through the 19th centuries, the dominant practitioners of bloodletting weren’t physicians — they were barber-surgeons. The medical establishment of the day considered surgery beneath them, so the work fell to barbers, who already handled sharp implements and had the temperament for it. By 1163, a church edict had formalized the arrangement, limiting monks to the care of souls and handing bloodletting and dentistry to the barber-surgeons. They developed a thriving, guild-organized trade that lasted for centuries.

Their primary tool for venesection was the fleam or lancet — a small, sharp blade used to nick a vein and let blood flow. The goal was volume. Patients were bled until they felt faint, sometimes until they actually fainted, in the belief that restoring humoral balance required removing substantial quantities of blood. For a procedure that depended entirely on getting a vein open and flowing, finding and accessing that vein was everything.

And here’s where we can first trace the practice: barber-surgeons learned, empirically, that wrapping a band or ligature around the arm above the site made veins swell and become easier to target with the lancet. Whether this was formalized as a technique or passed down as shop-floor knowledge isn’t entirely clear — the historical record is spotty, as you might expect from a guild of artisans rather than university physicians. But references to tourniquet-like bandages being used in venesection appear in early medical texts, with at least one noting that a ligature applied too close to the site could actually interfere with proper vein filling — evidence that practitioners understood the mechanics well enough to identify when they were doing it wrong.

There’s another detail from the barber-surgeon era that belongs in this conversation: the barber’s pole. Patients undergoing bloodletting were given a wooden rod to grip during the procedure. Squeezing the rod caused the forearm muscles to contract, pushing blood into the veins and making them bulge — the same reason we may ask patients to make and hold a fist today (remember, no fist pumping allowed). The barber’s distinctive red-and-white pole isn’t just a decoration. The red represents blood, the white represents the bandages used in the procedure, and the pole itself was the device patients gripped to raise their veins. Every time you walk past a barbershop, you’re looking at a 700-year-old phlebotomy instruction.

A Brief Detour: The Other Tourniquet

This is also the point where we should acknowledge the tourniquet most people think of — the surgical and trauma variety — because it shares a name with what’s on your cart but is otherwise a different device doing a different job.

The concept dates to ancient Rome, where soldiers used narrow bronze straps to stanch hemorrhage during battlefield amputations. It was brutal, practical, and effective enough that the basic design went largely unchanged for centuries — a band around a limb, twisted tight with a stick until the bleeding stopped. The Romans didn’t have a name for it. That came later.

The word tourniquet was coined in 1718 by French surgeon Jean-Louis Petit, from the French tourner — to turn — describing the stick used to twist a constricting band tight enough to stop arterial bleeding. Petit’s screw device formalized centuries of battlefield improvisation into a controlled, releasable mechanism, and the name stuck. By the time diagnostic venipuncture became standard practice in the early 20th century, “tourniquet” was already the established medical vocabulary for any constricting band applied to a limb. The word simply carried over — nobody sat down and named the rubber tubing phlebotomists were using. It was already called a tourniquet because that’s what you called things that wrapped around limbs and restricted blood flow.

The surgical tourniquet evolved significantly from Petit’s design — through Lister’s use of it to create bloodless operative fields in 1864, Esmarch’s rubber exsanguination bandage in 1873, and Harvey Cushing’s pneumatic cuff in 1904, which finally allowed precise, controllable pressure. That pneumatic cuff is the ancestor of the surgical tourniquet still used in operating rooms today, and it was engineered to do something the phlebotomy tourniquet specifically must not do: completely occlude arterial inflow and stop all blood movement. The venipuncture tourniquet works on an entirely different principle — partial venous occlusion while arterial flow continues, which is exactly what causes the vein to distend. Two devices, one name, opposite physiological goals.

Rubber Tubing and the Diagnostic Revolution

The bridge between the barber-surgeon’s bandage and the modern phlebotomy tourniquet runs through the early 20th century, when diagnostic blood testing transformed from a novelty into a cornerstone of clinical medicine.

By the turn of the century, clinical laboratories existed, but they were small and their role was limited. That changed rapidly. In 1908, Todd and Sanford published Diagnosis by Laboratory Methods, one of the first manuals to document formal venipuncture technique for diagnostic purposes. By the 1920s, diagnostic venipuncture had become widespread, and a new kind of practitioner — neither surgeon nor barber — was routinely drawing blood from patients who weren’t sick enough to be hospitalized, simply to run tests.

Those early practitioners needed a way to distend veins, and they used what was available: rubber tubing. A short length tied around the arm in a slipknot, snug enough to impede venous outflow without stopping arterial inflow, was the standard venipuncture tourniquet for decades. Penrose drains — flat rubber tubing designed as surgical wound drains — were so commonly pressed into service as tourniquets that some institutions stocked them specifically for the purpose. There was no purpose-built phlebotomy tourniquet. There was just rubber, and the knowledge, passed down from barber-surgeons through centuries of practice, that wrapping something around a limb made veins come up.

That changed on December 23, 1991, when four inventors at a company called Ingress Technologies filed a patent for the first purpose-built disposable phlebotomy tourniquet — US Patent 5540714, granted in 1996. The device was a single-use strip of coated elastic fabric, and the patent text is remarkably candid about what it was replacing: “a length of rubber tubing or strapping is commonly used for this purpose.” After roughly seventy years of rubber tubing doing an adequate job, someone finally designed something better.

What drove the invention wasn’t a new understanding of vein physiology. It was fear. The patent was filed at the height of the AIDS epidemic’s transformation of clinical practice, in the same cultural moment that made disposable syringes, single-use needles, and latex gloves mandatory. Reusable rubber tourniquets — handled by every clinician, stretched across patient after patient, rarely cleaned — were a quiet infection control problem. The disposable phlebotomy tourniquet was the solution, born not from curiosity about veins but from the urgent need to stop passing blood-borne disease between patients.

Latex allergy recognition in the late 1970s and an FDA latex labeling requirement in 1998 pushed manufacturers further toward non-latex alternatives. The patent itself expired in 2013. The reusable tourniquet that lived in a clinician’s coat pocket for weeks or months — studies found some had been in continuous use for nearly two years, with contamination rates for MRSA documented in the research — gave way to the bright-colored single-use strips that stock every draw station today.

What took even longer to sort out was how long the tourniquet should actually stay on. The device itself was refined over decades, but the question of what it was doing to the specimen in the meantime went largely unasked. That reckoning came later.

What Happens After Sixty Seconds

The moment you apply a tourniquet, a clock starts running. In the first minute or so, the effects on your specimen are minimal and generally acceptable. After one minute, hemoconcentration begins.

Hemoconcentration happens because the tourniquet doesn’t stop everything — it impedes venous outflow, but arterial pressure continues pushing plasma out of capillary beds and into surrounding tissue. What’s left behind in the vein becomes progressively more concentrated. Proteins, cells, large molecules, and analytes that bind to proteins all rise relative to their true values. Studies have documented statistically significant increases in serum potassium, total protein, cholesterol, and calcium after even one minute of tourniquet application. And hemolysis risk climbs steeply: one study found the odds ratio for hemolysis when tourniquet time exceeded one minute was 19.5 — nearly twenty times the baseline risk.

CLSI recognized this and addressed it in GP41: apply the tourniquet, complete your vein assessment, and draw within one minute. If a suitable site hasn’t been found in sixty seconds, release the tourniquet and wait at least two minutes before reapplying, allowing the concentrated blood to equilibrate back to baseline.

The problem is that this guideline is widely disregarded in practice — not out of malice, but out of habit and time pressure. One study measured average tourniquet application time before a training intervention and found the mean was 118 seconds. Nearly two minutes. Every day, in labs across the country, clinicians are reading potassium values that were elevated before the blood ever left the arm.

There will be another post in the future that discusses all this in more detail. Stay tuned.

The Tool That Forgot Its Own History

The barber-surgeons who wrapped bandages around arms in medieval barbershops and the phlebotomists snapping on rubber strips in a modern hospital draw room are doing something recognizably similar, for a recognizably similar reason. They both learned — through experience, observation, and accumulated practice — that partial constriction of a limb brings veins to the surface. No controlled trial established this. No inventor named it. It is one of the oldest techniques in our professional lineage, and it arrived in our hands without a timestamp.

What we did add, eventually, was the science: the understanding of why it works, what it does to the specimen, and exactly how long we have before the tool that helps us find the vein starts quietly corrupting what we collect from it.

The barber-surgeons bled patients to the point of fainting and called it medicine. We’ve come a long way. But we’re still squeezing the same basic principle out of the same basic idea. Sixty seconds. Then let go.

Check out this laminated badge tag, punched for easy attachment to lanyards and ID badges, keeps the Order of Draw for blood collection tubes and seven key tips in handling blood samples right where it's needed for easy reference. Perfect for anyone who performs blood collections!

Subscribe now

Share

Leave a comment

The whole time I was getting my blood drawn, she used pet names. “Take a seat here, hun. Little poke now, honey.” It bothered me every time she said it. I had just been told that I had diabetes, and this was an antibody blood test to determine if it was type one or type two. (It ended up being type 1 — yay for autoimmune diseases.)

I was in disbelief, stressed, and every time she called me one of those names or popped her gum, it came off as dismissive and a little condescending. I was extra sensitive that day, and it bothered me more than it normally would. I know she didn’t mean anything by it, but on top of the other mistakes she was making during the blood draw — and there were many — it just added to the stress I was already carrying.

I smiled. I didn’t say anything. But I noticed it.

I’ve been on the receiving end of “sweetie,” “honey,” “hun,” and “darlin’” more times than I can count, and I’ve had plenty of time to think about how each one lands. Sometimes I can feel genuine warmth behind it — a person who truly cares, whose affection spills over into their word choices. Sometimes it’s clearly a habit, the verbal equivalent of autopilot, a filler word that comes out without any real intention behind it. And sometimes — not always, but sometimes — it feels like being talked down to. Like I’m not a professional adult in a clinical setting. Like I’m being managed rather than respected.

None of those three versions is what we should be going for.

The Habit We Don’t Notice

Here’s the thing about terms of endearment in healthcare: most people who use them aren’t trying to be condescending. They’re not trying to make patients feel small. In many cases, they genuinely believe they’re being warm and personable — putting patients at ease, softening an experience that can be stressful and uncomfortable, especially on top of the other concerns they may be dealing with.

And I get that instinct. Phlebotomy is an intimate procedure. You’re in someone’s personal space, touching their arm, causing a brief moment of pain. Building rapport matters. A kind tone, a gentle approach, a reassuring presence — these are real skills and they make a real difference.

But “sweetie” isn’t rapport. It’s a habit. And habits are worth examining.

These terms are more common in certain regions and workplace cultures — the South, in particular, has a long tradition of using endearments casually — and that familiarity can make them feel harmless. Normal. But “common” is not the same as “appropriate,” and “well-intentioned” is not the same as “professional.” When we’re in a clinical role, the standard shifts.

You’re Being Recorded

I want to say something that I think about every single time I see a phlebotomist interact with a patient, and I think more of us need to internalize it:

You may be on camera right now.

Patients record their healthcare encounters. They do it openly, they do it quietly, sometimes secretly, and they do it constantly — on their phones, on their smartwatches, their glasses, in ways you would never notice. Sometimes it’s because they’re scared and want to remember what was said. Sometimes it’s because they’ve had a bad experience before and want documentation. Sometimes they are trying to just get views with big goals to become an influencer, and sometimes they share it. Online. To thousands of people.

Ask yourself honestly: if this interaction were posted to social media tomorrow, would you be comfortable with how you addressed that patient? Would your facility be comfortable? Would your manager?

Calling a patient “honey” in a moment of genuine warmth might feel like a non-issue in the moment. On video, reviewed by strangers, it can look dismissive. Condescending. Unprofessional. Too familiar. It can reflect poorly not just on you, but on your entire organization.

This isn’t about fear. It’s about consistency. The standard of professionalism you hold in your best moments should be the same standard you hold when you think no one is watching. Maintain your ethics and integrity, always.

It’s Not Your Call

Here’s something else worth sitting with: when you call a patient “sweetie,” you’ve made a decision about how they want to be addressed without asking them.

You don’t know who that person is when they walk out of your collection area. You don’t know if they’re a judge, a teacher, a surgeon, or a grieving parent who just got a frightening diagnosis. You don’t know how they feel about pet names, whether they find them comforting or infantilizing, or whether they’ve spent their whole life quietly bristling at being called something other than their name.

You also don’t know how they identify. The safest, most universally respectful approach — for every patient, regardless of age, gender, background, or presentation — is the same: use their name. It’s right there on the requisition. It costs you nothing, and it tells that person, in a small but meaningful way, that you see them as an individual.

If you genuinely don’t know how a patient prefers to be addressed, ask. “How would you like me to address you?” takes three seconds. It signals respect. And it removes any guesswork about whether your chosen term is landing the way you intended.

What to Do Instead

The good news is that the fix is simple, even if breaking the habit takes some effort.

Before you even know a patient’s name — when they’re walking through the door and you’re confirming who they are — you have perfectly good options. “Ma’am, are you here for a blood draw?” “Sir, can I get your date of birth?” “Miss, I’ll be right with you.” These are professional, respectful, and they require zero information about the person standing in front of you. They signal that you’re attentive and courteous without assuming any level of familiarity. That’s exactly the tone you want to set before the interaction even begins.

Of course, gendered titles only work when you’re confident they fit. With transgender and non-binary patients making up a growing part of the population, there will be times when you’re genuinely unsure — and that’s okay. In those moments, skip the title entirely and go straight to the name. You’re about to confirm their identity anyway, so you’ll have it within seconds. “Hi, I’ll be drawing your blood today — can I get your name and date of birth?” is professional, warm, and sidesteps the issue entirely. No awkwardness, no misstep, no big deal.

Once you have their name — and you usually will if they have a requisition — use it. A title and a last name, or just a first name — follow the patient’s lead once they’ve introduced themselves. If you don’t have a strong preference, first name is almost always appropriate and immediately personalizes the interaction without crossing into overfamiliarity.

Watch your autopilot. If “honey” or “sweetie” is coming out of your mouth without you consciously choosing it, that’s the signal to slow down. Habits don’t disappear on their own — they have to be interrupted. Pay attention to what you’re saying during patient interactions for a few days. You might be surprised.

Don’t overcorrect into coldness. Warm, professional, and personal are not mutually exclusive. You can be genuinely kind and caring without relying on pet names to signal it — and honestly, the things that actually make patients feel cared for have nothing to do with what you call them.

Smile when you greet them. Make eye contact. Speak in a friendly, unhurried voice even when you’re slammed and running behind. If a patient has a question, stop and answer it — really answer it, not just a brush-off on your way to the next arm. Explain what you’re doing before you do it. Acknowledge when someone seems nervous. These are the things patients remember. These are the things that make someone leave your draw station feeling like they were seen and taken care of. A warm tone and genuine attentiveness will do far more for patient experience than any pet name ever could — and they hold up under any scrutiny.

A Note on the Flip Side

Patients will call you pet names too. “Thank you, honey.” “You’re so good at this, sweetie.” It happens constantly, and it almost always comes from a place of genuine gratitude or affection.

You don’t have to hold patients to the same standard you hold yourself. They’re nervous, they’re vulnerable, and when someone just made an uncomfortable experience easier, they sometimes reach for the warmest word they know. That’s human. Let it be human.

But it’s worth noticing the double standard — and letting it remind you of how quickly and automatically those words come out when we’re trying to express care. Your patients are doing the same thing you might be tempted to do. The difference is that you’re the professional in the room.

That said, there’s a line. If a patient’s familiarity crosses into something that feels inappropriate or predatory — and unfortunately it happens — you don’t have to tolerate it. Ask them to stop. Tell your manager. And if the behavior continues, it’s completely reasonable to refuse to serve that patient again. Being professional doesn’t mean being a target.

What Patients Remember

Phlebotomists are often the first hands-on contact a patient has in a healthcare encounter. That moment sets a tone — for their experience with you, and sometimes for their experience with the entire facility.

Calling someone by their name instead of “sweetie” won’t make you less warm. It won’t make the interaction feel clinical or cold. What it will do is communicate something important: that you see this person as an individual who deserves to be addressed with the same respect you’d want for yourself.

You are the professional. You set the standard. Make sure it’s one you’re proud of.

Looking for short training t

opics for your staff? We have abbreviated teaching modules made just for you! Our ATMs are short articles on a wide variety of topics your collection staff should know. Simply distribute them to your staff, collect the answers to the accompanying quiz, grade, file, and get on with your day. Available in bundles or individually.

Subscribe now

Share

Leave a comment

So we started troubleshooting. I walked her through the usual questions. Was she mixing too vigorously? Underfilling tubes? Drawing from compromised sites? No, no, and no. She was thoughtful about all of it. And then I asked what needle she was using.

“A 25 gauge butterfly. For every patient.”

I paused. “Every patient?”

“Every single one. I don’t want to hurt them.”

There it was. She had chosen the smallest gauge butterfly available and was using it universally — not out of laziness or ignorance, but out of genuine, heartfelt empathy. She didn’t want her patients to feel pain. What she didn’t realize was that in trying to prevent one small harm, she was causing several larger ones.

The Problem With Misapplied Empathy

Her intention was good. Her application was off. And honestly, I’ve seen this more times than I can count — not just with needle selection, but across all kinds of technique decisions. We want to protect our patients, and sometimes that impulse leads us somewhere that doesn’t actually serve them.

Here’s what her patients were experiencing instead of a brief, potentially slightly sharper stick: hemolyzed specimens, rejected by the lab. A call to come back for another draw. Delayed results. Delayed diagnoses. Delayed treatment. The frustration of a healthcare system that already feels like it never gets it right the first time.

Hemolysis is the number one cause of rejected chemistry specimens — accounting for six times more rejections than the second most common reason, insufficient sample volume. It is not a minor inconvenience. It is the single biggest quality problem in specimen collection, and the majority of it is preventable.

The brief sting of a correctly sized needle is almost always less of a burden than everything that follows a hemolyzed specimen. Real empathy — the kind that actually helps patients — sometimes means making the choice that feels slightly less gentle in the moment because it produces a better outcome overall.

Plus, it isn’t usually the size of the needle gauge that determines the pain level, it’s more about the technique. It’s the way it’s used that can lessen or worsen the pain someone experiences.

What’s Actually Happening Inside That Needle

To understand why needle gauge affects hemolysis, it helps to think about what blood is asked to do when it passes through one.

Red blood cells are flexible, but they’re not indestructible. When blood is forced through a narrow bore under vacuum pressure, the flow becomes turbulent. Cells that were traveling smoothly get churned, compressed, and sheared against the walls of the needle. The smaller the bore and the stronger the vacuum, the more violent that turbulence becomes — and at some point, more red cells don’t survive the trip intact.

The research suggests the clinically significant threshold is at 25G. A 2006 study by Lippi and colleagues compared 21G, 23G, and 25G butterfly needles under controlled conditions and found that 23G needles, when handled correctly, do not introduce statistically or clinically significant error compared to a 21G needle. It’s the step down to 25G where things break down — that gauge showed meaningfully increased variability for potassium, the analyte most sensitive to hemolysis. The authors concluded that 25G needles cannot be universally recommended for routine blood collection and should be reserved for newborns or patients with truly problematic venous access.

That doesn’t mean 23G is consequence-free — technique still matters enormously at any gauge, and the physics of turbulent flow don’t disappear just because the research didn’t flag a statistically significant difference. But it does mean that a well-executed draw with a 23G butterfly on an appropriate patient is a reasonable clinical choice. A 25G on every patient, regardless of vein quality, is not.

This brings us to why butterfly needles are disproportionately associated with hemolysis problems in practice — and it’s not because of the butterfly format itself. A same-gauge butterfly and straight needle perform similarly. The issue is the gauge options each device comes in. Straight needles for routine blood collection are typically available in 21G and 22G. Butterfly needles are routinely available in 21G, 23G, and 25G. That range of smaller gauges, combined with the habit of reaching for a butterfly when a draw feels difficult, is what drives the hemolysis connection. The butterfly becomes the vehicle for a gauge choice that wouldn’t even be available with a straight needle.

The result is hemolysis: ruptured red blood cells releasing their contents into the serum. And the clinical consequences are significant. Red blood cells contain 23 times more potassium than the liquid portion of blood — so when cells rupture during collection, the specimen gets flooded with intracellular potassium. A falsely elevated potassium result can send a physician into a panic and trigger treatment the patient doesn’t need. Or, if the patient’s actual potassium is dangerously low, hemolysis can mask it by pushing the result into a normal range — leading to inaction when action is critical.

Potassium isn’t the only concern either; LDH, AST, ALT, phosphorus, magnesium, and ammonia are all affected, along with virtually any analyte diluted by the hemoglobin now flooding the serum. Depending on how obvious the hemolysis is, the lab can usually catch it, but not always. So can you, once you know what to look for: that telltale pink or red tinge to the serum that tells you the specimen is compromised.

The goal isn’t to find the smallest gauge that won’t cause visible hemolysis — it’s to choose the largest gauge the vein can reasonably accommodate. A 21G on a good antecubital vein is almost always the right answer for a routine draw. Reserve smaller gauges for situations where the vein genuinely requires it, and understand that when you do go smaller, specimen quality is a real tradeoff you’re making.

It’s Not Just the Needle Gauge

Needle selection is the most common culprit, but it’s not the only way technique causes hemolysis. Here’s what else to watch for — and teach:

Pulling a syringe too fast. When you’re using a syringe for a difficult draw, it’s tempting to pull back quickly to establish flow. But excessive negative pressure creates the same turbulence problem as a small gauge needle. Pull slowly and steadily, letting the vein fill the syringe at its own pace.

Partial bevel occlusion. If the needle bevel is pressed against the vein wall, blood is being forced through a partially blocked opening. The resulting turbulence shears red blood cells before they even reach the tubing. If flow is sluggish, don’t pull harder — reposition.

Blood hitting the tube wall at high velocity. This one is underappreciated. When a tube is nearly empty, blood can strike the dry glass or plastic wall with enough force to cause mechanical hemolysis. On slow draws, consider angling the tube slightly so blood runs down the side rather than dropping straight in — though this is more of a fine-tuning consideration than a primary cause.

The butterfly dead space problem. Here’s something many phlebotomists have never thought about: when you’re using a butterfly needle, there are several inches of tubing between the needle and the collection tube. Blood enters that tubing before it ever reaches the tube — and on a slow draw, it can sit there longer than you’d think. That blood is exposed to temperature change, movement, and the shear stress of the initial draw. On fragile specimens or very slow draws, this dead space can contribute to hemolysis even before a single drop hits the tube. It’s one more reason that butterfly needles, while invaluable in the right situations, aren’t a universally gentler option just because they feel more controlled.

Over-vigorous mixing. Inversion is necessary — but there’s a meaningful difference between gentle end-over-end inversions and shaking the tube like a snow globe. Each tube type has a specified number of inversions for a reason. More is not better. Aggressive mixing after collection is a common and entirely preventable cause of hemolysis.

Underfilled tubes. When a collection tube isn’t filled to its intended volume, the ratio of additive to blood is off — there’s proportionally too much anticoagulant or other additive relative to the sample. That chemical imbalance can be hard on red cell membranes and contribute to hemolysis, particularly in EDTA tubes where excess anticoagulant is especially disruptive to cell integrity. Always fill tubes to their stated volume, and keep smaller draw tubes on hand when a difficult or low-yield draw is anticipated.

Site and patient factors. Drawing from edematous tissue, severely cold extremities, or a site with compromised circulation introduces variables that increase hemolysis risk. These situations call for adjusted technique — slower draws, smaller gauge if truly warranted, careful site selection — not just the same approach applied to a harder problem.

Vascular access devices. IV’s, central lines and PICC lines are designed primarily for infusion, not blood withdrawal. The shear forces and turbulence generated through those systems are often more than fragile red cells can handle. When a VAD draw is unavoidable, use a syringe and apply the gentlest possible pulling pressure — and be prepared to perform a venipuncture anyway if the specimen is unacceptable. Only nurses can typically access these devices anyway, but phlebotomists or medical assistants can sometimes access IV’s to draw blood. This should only be done when a peripheral stick is not possible, and the same principle applies: slow, gentle syringe pressure and careful attention to specimen quality. Drawing blood from these VADs cause some of the worst hemolysis rates.

Capillary collection and milking. Fingersticks and heelsticks carry their own hemolysis risks, and the biggest one is excessive milking of the site. When blood flow is poor and collectors squeeze aggressively to get enough volume, the mechanical pressure ruptures cells before they even leave the tissue. The prevention is pre-warming — a warm compress applied to the site before collection increases local blood flow dramatically and reduces the need to milk. If you find yourself squeezing hard to get a capillary specimen, stop and ask whether adequate warming was done first. It’s better to stop and try again.

When a Butterfly Is the Right Call

I want to be clear: butterfly needles are excellent tools. They exist for good reasons, and used appropriately, they make difficult draws possible. Hand veins, small or rolling veins, pediatric patients, elderly patients with fragile vessels — these are the situations where the stability and control of a winged set genuinely serve the patient.

However, along with 25 gauges, many of the technique and collection problems are associated with butterflies (slow draw, small veins, bevel against a wall etc.) That’s why it’s better to search for a good AC vein and perform the puncture with a straight needle when possible.

But even when a butterfly is the right choice, technique still matters enormously. Allow flow to establish slowly. Be patient with the tubing fill. Don’t pull vacuum aggressively through small gauge butterflies. And understand that choosing a butterfly doesn’t neutralize the other hemolysis risks — mixing, tube fill, draw speed all still apply.

The question to ask isn’t “is this patient delicate?” The question is “what does this specific draw actually require?” Sometimes the answer is a butterfly. Often, it isn’t.

(If you want the full story on the history of butterfly needles, when to use them, and why they carry a significantly higher accidental exposure risk than straight needles, I covered all of that in depth in The History of Butterfly Needles: And Why You Shouldn’t Use Them for Everything.)

What to Tell Your Students and Staff

If you’re an educator and you’ve seen this pattern — the empathetic student or new hire defaulting to the smallest, gentlest-seeming tool for every patient — approach the conversation carefully. The impulse behind the behavior is worth preserving. You’re not trying to train empathy out of anyone. You’re trying to redirect it.

Try this framing: The most compassionate thing you can do for your patient is get it right the first time. That means choosing the tool that’s appropriate for the draw, not the tool that feels the most protective. A correctly sized needle, used well, results in one stick, an intact specimen, accurate results, and a patient who goes home without waiting for a callback.

My former student remembered and understood this immediately when we talked through it. She wasn’t defensive — she was mortified that she’d been causing extra sticks and delayed results while trying to do the opposite. That mortification turned into motivation, and last I heard, her rejection rates had dropped significantly.

Her patients were better off for it. And so was she.

Have a technique question or a story of your own? I’d love to hear it in the comments.

Subscribe now

Share

Leave a comment

Check out our Lab Draw Answer Book - full of answers to hundreds of commonly asked questions on drawing blood samples for laboratory testing, including topics like causes of hemolysis.

I was there as a speaker. I ended up as a student.

The first speaker was Ayla, MLS(ASCP)CM, a microbiologist with four years of experience working exclusively in microbiology at a Colorado hospital. Ayla talked about innovations in automated microbiology systems and digital plate reading — technology that is changing how labs identify pathogens and report results. She described how these new machines were being implemented at the facilities where she had worked, the advantages and disadvantages, how they affected the daily workflow, and how they simplified and sped up certain aspects of culture testing. Nearly every hand in the room went up with questions about how things had been done in the past versus how the new process handled them now.

Ayla had an answer for every single one. She was not a representative of the company selling these machines. She was simply well-trained, deeply knowledgeable, and clearly passionate about her field. She was teaching things to women with decades of lab experience who were leaning forward in their seats. The energy in the room was lively, and her excitement to share about her daily work was electric. It was heartwarming to watch a room full of people hang on every word of a lecture that most people would assume was dry — I have sat through similar topics barely keeping my eyes open. She had the room enthralled.

The second was Hayley, MLS(ASCP)CM, who has spent the last six-plus years working the night shift in the Blood Bank at a children’s hospital. Hayley walked us through the process of performing newborn blood type workups — specifically what happens when that newborn has AB negative blood and clinically significant maternal antibodies present. She gets one drop of plasma from a whole blood sample. One drop. That drop gives her roughly two dozen tiny samples to use for the entire workup in reverse antibody testing.

In the scenario she walked us through — and my apologies, Hayley, if I get some of these details wrong — I believe the newborn had been life-flighted to the hospital, was dealing with serious life-threatening complications, and had already reached the maximum safe blood collection volume for various tests. No mother present for testing either. That means no do-overs, no sending someone back for another sample. One drop of plasma to determine the blood type through a process I had no idea was so complicated.

I had always imagined that we send a sample to the lab, they put it in a machine, and bam — blood type confirmed. I was wrong.

The process she walked us through was methodical, precise, and unforgiving. It takes focused, careful time to rule out each antibody one by one. No popping it in a machine and waiting for a beep — she works through every step herself. Every variable has to be considered. Every possibility has to be ruled out. And the stakes couldn’t be higher: this is a newborn, possibly hours old, whose blood type and antibody status will directly affect clinical decisions about their care. Hayley described it matter-of-factly, the way people do when they’ve internalized something so completely it no longer registers as remarkable. What she was describing sounded more like disarming a bomb than what I had imagined my whole career.

I sat there thinking about heel sticks. About tiny 24 gauge IVs placed in a scalp vein, blood dripping into a microcollection container — a method that, while sometimes necessary, carries a real risk of hemolysis in those already precious few drops. About the phlebotomists and nurses collecting those specimens — the tiny volumes, the careful technique required, the absolute criticality of not hemolyzing that sample. A hemolyzed specimen from a bad collection isn’t just an inconvenience. In this context, it could mean compromising the only plasma available for a workup that cannot be repeated.

For my part, I have been the one at the bedside drawing blood from a freshly delivered baby — sometimes so fresh they are still covered in wet baby goo (vernix). You always know that blood is precious cargo. I never knew what the lab scientist was going through in their windowless room on the other side of that specimen.

Both of them were young. Both of them were passionate in a way that was genuinely contagious. Both of them clearly care very deeply about their careers and their patients. It filled me with hope, excitement for the future of healthcare, and a renewed appreciation for all of our friends in the lab.

A Week Worth Knowing About

Medical Laboratory Professionals Week — Lab Week, as most people in healthcare call it — runs April 19–25 this year. Lab Week has a history worth knowing, because in many ways it’s the origin story of the world phlebotomy grew out of.

Clinical laboratory science as a formal profession began taking shape in the early twentieth century. Hospitals scrambling to meet accreditation requirements after World War I needed trained laboratory staff, and by the 1930s, the American Society for Medical Technology — what would eventually become the American Society for Clinical Laboratory Science, or ASCLS — was established to represent them. The profession was growing, but it was largely invisible. Physicians ordered the tests and received the results. The people doing the work in between went unrecognized.

That changed in 1975, when ASCLS inaugurated the very first National Medical Laboratory Week — a deliberate, organized effort to say: we exist, this work matters, and the public deserves to know who is doing it. Today the week is coordinated by a coalition of 18 national laboratory organizations — ASCLS and ASCP among the most prominent — and celebrated in hospitals, clinics, and labs across the country every April. The 2026 theme is “Lab Story: To Infinity and Beyond for Our Patients.” Having sat in a room listening to Hayley and Ayla, I can tell you that theme lands.

One Chain, No Weak Links

Here is what I want phlebotomists to understand, and what I want our friends in the lab to know we understand: what we do and what they do are not separate things. They are one continuous process, and every link matters.

Consider what happens when a blood culture is drawn with poor technique — skin flora introduced into the bottle, aseptic protocol skipped or rushed. That contaminated culture doesn’t just create extra work. It can trigger a cascade: a clinician chasing a false positive infection, a patient started on antibiotics they may not need, days of anxiety and unnecessary treatment while the repeat culture processes. Behind every contaminated blood culture result is a collection that didn’t meet the mark. Ayla lives on the receiving end of that. She analyzes the cultures, identifies types of growth and provides critical information for diagnosis and treatment. She catches the false positives and prevents unnecessary antibiotics, longer hospital stays, and physician frustrations.

The same is true for Hayley’s world. The roughly two dozen samples she works with from a single drop of neonatal plasma don’t appear out of thin air — they come from an infant who cannot tell the phlebotomist if it hurts, who must use technique careful enough not to hemolyze that sample. A hemolyzed neonatal specimen doesn’t just complicate the result — it may render that plasma unusable entirely, leaving the lab to make critical decisions with even less to work with. The lab result is only as good as the collection that preceded it. We know this. We teach it. But hearing it from the other side — from someone who lives with the consequences of our work every single shift — makes it real in a different way.

Phlebotomists who understand what happens to their specimens after they leave the collection site are better collectors. The more we know about each other’s world, the better we each do our jobs.

Lab Week is a celebration of the people who work largely out of sight, running the tests that drive an estimated 70 percent of all clinical decisions. Phlebotomists are the first chapter of every one of those stories. The lab worker is the chapter that makes sense of it.

Happy Lab Week to all of our friends in the lab — and a particular thank-you to Hayley and Ayla, who reminded a room full of experienced healthcare professionals that there is always more to learn, and that with people like those two, the future is bright.

Please take a few minutes to stop by your lab and thank our friends who do such critical work and rarely get any appreciation.

Looking for training videos for your phlebotomists? We have them — and our videos are now able to embed directly into your LMS. Reach out to us for more information :)

Subscribe now

Share

Leave a comment

Not a modified pencil grip, not something I could charitably interpret as an awkward-but-fixable angle. A full, fingers-curled, number-two-pencil grip on a straight needle. And they were fully prepared to insert it that way into a human arm.

They had sat through the lectures. They had watched the demo. In their mind, they understood. And then they picked up the needle and showed me something that would have made anyone scratch their head.

That moment — and every version of it I witnessed over the years — is why I became a passionate advocate for fake practice arms. Not as a nice-to-have, not as a budget luxury, but as a non-negotiable step in preparing students to stick real patients.

How I Was Trained (And What That Cost Us)

When I learned phlebotomy, the training model was straightforward: listen to the teacher, watch a video, watch a live demonstration, then do it yourself on a real person. That was it. That was the pipeline from novice to needle.

I didn’t think much about it at the time. That was how it was done, so I assumed that was how it should be done. When I became an instructor in the early years of my teaching career, I carried that model forward. We had a few training aids, but they weren’t a dedicated focus. Students practiced what they could, then very quickly moved to live draws.

I don’t think I was necessarily wrong to follow that model — it was what I knew, and plenty of competent phlebotomists had come out of it. But looking back now, I can see what I was missing.

When the Budget Changed, So Did the Results

As our program grew and the budget allowed, I invested in a proper set of practice arms — enough that every student could have meaningful, extended time with one before we ever moved to live practice. And with that change came a shift I didn’t fully anticipate.

The difference on that first night of live draws was not subtle.

Students who had spent a couple of hours working through the mechanics on a practice arm were noticeably more prepared. Their grip was steadier. Their angles were more consistent. They knew where the needle was going before they moved it there. They didn’t look like they were encountering the equipment for the first time, because functionally, they weren’t.

Compare that to earlier cohorts who had gone directly from seeing the equipment, listening to a lecture, watching a demo, then person to person, and the gap was clear. More hesitation. More grip adjustments mid-draw. Way more time spent with each student answering questions and fixing errors. More of that panicked pause when something didn’t feel right and they didn’t have the muscle memory to fall back on.

This wasn’t a controlled study. But I’ve been in enough clinical education to know what prepared looks like, and the arms made a measurable difference.

The Real Value: What Gets Caught Before It Reaches a Patient

Here’s the part that instructors don’t always talk about, but probably should: practice arms aren’t just for building skill. They’re for catching disasters before they happen.

And I mean that almost literally.

When students first pick up a needle in a supervised practice setting, you find out quickly what they actually understood versus what they thought they understood. Those two things are often very different.

The pencil-grip student I mentioned at the beginning wasn’t unique. Over the years I have seen students insert needles bevel-down. I saw grips and approaches I couldn’t have imagined or anticipated, because the human brain is creative in ways that instructional design simply doesn’t account for. Many times I watched students who had sat attentively through every lecture and nodded along with every demonstration pick up a needle and do something that would, on a real patient, have caused real harm.

Here’s what practice arms make possible that nothing else can: correction without consequence.

A fake arm doesn’t have nerves. It doesn’t bruise. There’s no patient sitting in the chair growing increasingly anxious while you gently explain (again) to your student that the bevel goes up. You can stop, redirect, demonstrate again, and have the student practice the correct technique immediately — on the same arm, in the same moment. The correction loop is tight. The lesson is immediate. And the patient is exactly where you want them: out of it entirely.

And to be clear — a student holding a needle incorrectly was never going to get a live stick in my program. The fake arms help students learn correct techniques, but what it really does is compress the time it takes to get past the basics. By the time my students moved to live practice, we weren’t standing there correcting grip and bevel orientation. We were working on the finer points: angle adjustment, palpation confidence, reading patient feedback, managing a difficult draw. The simulation time bought us that. It moved the floor up.

Lecture Does Not Equal Understanding

If I could go back and say one thing to myself as a new instructor, it would be this: watching is not doing, and understanding in the abstract is not the same as understanding in the hands.

Have you ever watched a skill and thought that you could easily do it, but as soon as it was your turn to perform you suddenly have no idea what the steps were? Students can absorb a lot of information in lecture format. They can follow along with a live demonstration and feel confident they’ve captured it. But the moment they pick up a needle, something changes. The knowledge has to translate into physical execution, and that translation is where things fall apart.

Motor skills don’t develop by watching. They develop by doing — and ideally, by doing with immediate feedback in a low-stakes environment. Practice arms provide exactly that. They create a space where students can fail, get corrected, and try again without any of the variables that make live practice so unforgiving.

The research backs this up clearly. A systematic review of 15 studies on clinical simulation found consistent evidence of improved student confidence in performing clinical tasks, communicating with patients, and making clinical judgments. Separate research on simulation in nursing education describes the protected environment of simulation as something that “enhances students’ self-esteem and confidence, promoting learning and substantially reducing the gap between theory and practice.” And it’s not just a short-term boost — studies have found that skill gains from simulation persist over time, with improvement documented even a month after training.

There’s also an interesting phlebotomy-specific study. Researchers who developed a simulation-based phlebotomy training program for new medical residents — people who had already completed medical school and passed board exams but had almost no hands-on draw experience — found participants rated the program between 4.3 and 4.8 out of 5 across every measure of satisfaction.

It was a short training session where they learned about venipuncture, practiced on fake arms, and then practiced on each other. Normally these medical residents learned the theory of phlebotomy in class, but were expected to perform these skills for the first time on actual patients — which is how many similar programs operate. The residents reported that it improved not only their technique, but their empathy for patients. When you’ve been on the receiving end of a needle yourself, even a simulation needle, you draw differently.

Those “pencil-grip” students? We catch it. We correct it. We have them practice the right way a dozen more times before they ever touch a real vein.

“Sink or Swim” Is Not a Teaching Philosophy

I want to address something directly, because I’ve encountered it more times than I’d like: the instructor who views practice arms as hand-holding, who believes the best way to learn phlebotomy is to simply do it on a real person and figure it out.

I understand where that mentality comes from. Many of us were trained that way. Some instructors see struggle as character-building, or interpret structured simulation as coddling students who need to toughen up. And there’s a kernel of truth buried in there somewhere — students do eventually need to work through the discomfort of live practice, and over-sheltering them creates its own problems.

But there is a meaningful difference between productive discomfort and avoidable harm. Sending an unprepared student to practice on a real person isn’t grit-building. It’s a failure of scaffolding.

Think about what it actually feels like to perform a clinical skill on a live human being for the very first time, with no prior hands-on preparation. The anxiety is real. The physical feedback is different from anything you’ve encountered on a model or in a video. The patient is watching you. Your hands may be shaking. That is not the moment to also be figuring out how to hold the needle, or how to activate the safety.

I’ve been that student. The first time I drew blood was on a real person, with a demonstration and nothing more behind me. I got through it, but I was terrified — and I was operating on adrenaline more than skill. When I think about my situation I wish I had the opportunity to spend more time practicing and understanding, rather than just trying to mimic what I had watched.

Our job as instructors isn’t to see who survives. It’s to prepare students so thoroughly that their first live draw feels like the next logical step in a progression — not a leap off a cliff.

A Note for Programs With Limited Budgets

I know not every program can afford a full classroom set of training arms, because I was running one of those programs once. If your budget is limited, here’s what I’d say: even one or two arms, used strategically with small groups or as a rotation station, is better than none. Students benefit from even an abbreviated session if it’s structured and supervised.

There are several versions available out there that are extremely affordable compared to how much they cost ten years ago ($500+). They start around fifty dollars on Amazon. It’s worth it to have a few.

The goal isn’t perfection before live practice. It’s baseline competency, verified technique, and at least some opportunity to fail safely before the stakes go up.

Future patients will thank you for it, even if they never know the planning and practice that a student goes through to be properly trained.

REMINDER that next week is LAB WEEK April 19-25! The theme is “Lab Story: To infinity and beyond for our patients!” Check out more at ASPC.org.

You can also purchase gifts from the Center for Phlebotomy Education at Phlebotomy.com, we have books and pens and badge tags and other goodies for all of our blood-drawing friends.

Subscribe now

Share

Leave a comment